1
|
Bai D, Cheng H, Mei J, Tian G, Wang Q, Yu S, Gao J, Zhong Y, Xin H, Wang X. Rapid formed temperature-sensitive hydrogel for the multi-effective wound healing of deep second-degree burn with shikonin based scar prevention. Biomater Adv 2024; 160:213851. [PMID: 38642517 DOI: 10.1016/j.bioadv.2024.213851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/11/2024] [Revised: 04/03/2024] [Accepted: 04/06/2024] [Indexed: 04/22/2024]
Abstract
Burns are a significant public health issue worldwide, resulting in prolonged hospitalization, disfigurement, disability and, in severe cases, death. Among them, deep second-degree burns are often accompanied by bacterial infections, insufficient blood flow, excessive skin fibroblasts proliferation and collagen deposition, all of which contribute to poor wound healing and scarring following recovery. In this study, SNP/MCNs-SKN-chitosan-β-glycerophosphate hydrogel (MSSH), a hydrogel composed of a temperature-sensitive chitosan-β-glycerophosphate hydrogel matrix (CGH), mesoporous carbon nanospheres (MCNs), nitric oxide (NO) donor sodium nitroprusside (SNP) and anti-scarring substance shikonin (SKN), is intended for use as a biomedical material. In vitro tests have revealed that MSSH has broad-spectrum antibacterial abilities and releases NO in response to near-infrared (NIR) laser to promote angiogenesis. Notably, MSSH can inhibit excessive proliferation of fibroblasts and effectively reduce scarring caused by deep second-degree burns, as demonstrated by in vitro and in vivo tests.
Collapse
Affiliation(s)
- Danmeng Bai
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, PR China
| | - Haoxin Cheng
- School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, Jiangxi 330088, PR China
| | - Junmin Mei
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, PR China
| | - Guangqi Tian
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, PR China
| | - Qingqing Wang
- School of Pharmacy, Nanchang University, Nanchang, Jiangxi 330006, PR China
| | - Simin Yu
- School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, Jiangxi 330088, PR China
| | - Jie Gao
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, PR China
| | - Yanhua Zhong
- School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, Jiangxi 330088, PR China
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, PR China
| | - Xiaolei Wang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, PR China; School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, Jiangxi 330088, PR China.
| |
Collapse
|
2
|
Zhao Z, Zhu J, Zhou L, Sun N, Chang K, Hu X, Hu Y, Ren M, Cheng Y, Xu D, Xin H, Zhang C. Establishment of a hydrodynamic delivery system in ducks. Transgenic Res 2024; 33:35-46. [PMID: 38461212 DOI: 10.1007/s11248-024-00377-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2023] [Accepted: 02/20/2024] [Indexed: 03/11/2024]
Abstract
Chronic hepatitis B virus (HBV) poses a significant global health challenge as it can lead to acute or chronic liver disease and hepatocellular carcinoma (HCC). To establish a safety experimental model, a homolog of HBV-duck HBV (DHBV) is often used for HBV research. Hydrodynamic-based gene delivery (HGD) is an efficient method to introduce exogenous genes into the liver, making it suitable for basic research. In this study, a duck HGD system was first constructed by injecting the reporter plasmid pLIVE-SEAP via the ankle vein. The highest expression of SEAP occurred when ducks were injected with 5 µg/mL plasmid pLIVE-SEAP in 10% bodyweight volume of physiological saline for 6 s. To verify the distribution and expression of exogenous genes in multiple tissues, the relative level of foreign gene DNA and β-galactosidase staining of LacZ were evaluated, which showed the plasmids and their products were located mainly in the liver. Additionally, β-galactosidase staining and fluorescence imaging indicated the delivered exogenous genes could be expressed in a short time. Further, the application of the duck HGD model on DHBV treatment was investigated by transferring representative anti-HBV genes IFNα and IFNγ into DHBV-infected ducks. Delivery of plasmids expressing IFNα and IFNγ inhibited DHBV infection and we established a novel efficient HGD method in ducks, which could be useful for drug screening of new genes, mRNAs and proteins for anti-HBV treatment.
Collapse
Affiliation(s)
- Zhanji Zhao
- Department of Pathology and Institute of Molecular Pathology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China
| | - Jiabing Zhu
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China
| | - Lijian Zhou
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China
| | - Nan Sun
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China
| | - Kaile Chang
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China
| | - Xiaoyue Hu
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China
- Institute of Translational Medicine, Jiangxi Medical College,, Nanchang University, Nanchang, 330031, People's Republic of China
| | - Yuting Hu
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China
- Institute of Translational Medicine, Jiangxi Medical College,, Nanchang University, Nanchang, 330031, People's Republic of China
| | - Mingzhi Ren
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China
| | - Yan Cheng
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China
| | - Derong Xu
- Institute of Translational Medicine, Jiangxi Medical College,, Nanchang University, Nanchang, 330031, People's Republic of China
| | - Hongbo Xin
- Institute of Translational Medicine, Jiangxi Medical College,, Nanchang University, Nanchang, 330031, People's Republic of China
| | - Chunbo Zhang
- Department of Pathology and Institute of Molecular Pathology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.
- Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Ministry of Education, Jiangxi Medical College, Nanchang University, Nanchang, 330031, People's Republic of China.
| |
Collapse
|
3
|
Gao J, Weng Z, Zhang Z, Liu Y, Liu Z, Pu X, Yu S, Zhong Y, Bai D, Xin H, Wang X. Traditional Scraping (Gua Sha) Combined with Copper-Curcumin Nanoparticle Oleogel for Accurate and Multi-Effective Therapy of Androgenic Alopecia. Adv Healthc Mater 2024; 13:e2303095. [PMID: 38175177 DOI: 10.1002/adhm.202303095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Revised: 12/13/2023] [Indexed: 01/05/2024]
Abstract
Androgenetic alopecia (AGA) is a prevalent systemic disease caused by diverse factors, for which effective treatments are currently limited. Herein, the oleogel (OG) containing copper-curcumin (CuR) nanoparticles is developed, designated as CuRG, which is also combined with traditional naturopathic scraping (Gua Sha, SCR) as a multifunctional therapy for AGA. With the assistance of lipophilic OG and SCR, CuR can efficaciously penetrate the epidermal and dermal regions where most hair follicles (HFs) reside, thereby releasing curcumin (CR) and copper ions (Cu2+) subcutaneously to facilitate hair regeneration. Concomitantly, the mechanical stimulation induced by SCR promotes the formation of new blood vessels, which is conducive to reshaping the microenvironment of HFs. This study validates that the combination of CuRG and SCR is capable of systematically interfering with different pathological processes, ranging from improvement of perifollicular microenvironment (oxidative stress and insufficient vascularization), regulation of inflammatory responses to degradation of androgen receptor, thus potentiating hair growth. Compared with minoxidil, a widely used clinical drug for AGA therapy, the designed synergistic system displays augmented hair regeneration in the AGA mouse model.
Collapse
Affiliation(s)
- Jie Gao
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, 330088, China
| | - Zhenzhen Weng
- School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330088, China
| | - Ze Zhang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, 330088, China
| | - Yuanyuan Liu
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, 330088, China
| | - Zikang Liu
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, 330088, China
| | - Xinyue Pu
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, 330088, China
| | - Simin Yu
- School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330088, China
| | - Yanhua Zhong
- School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330088, China
| | - Danmeng Bai
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, 330088, China
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, 330088, China
| | - Xiaolei Wang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, 330088, China
- School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330088, China
| |
Collapse
|
4
|
Ma T, Meng Z, Ghaffari M, Lv J, Xin H, Zhao Q. Characterization and profiling of the microRNA in small extracellular vesicles isolated from goat milk samples collected during the first week postpartum. JDS Commun 2023; 4:507-512. [PMID: 38045901 PMCID: PMC10692291 DOI: 10.3168/jdsc.2022-0369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/30/2022] [Accepted: 04/06/2023] [Indexed: 12/05/2023]
Abstract
Colostrum contains nutrients, immunoglobulins, and various bioactive compounds such as microRNA (miRNA). Less is known about the temporal changes in miRNA profiles in ruminant milk samples during the first week postpartum. In this study, we characterized and compared the profiles of miRNA in the small extracellular vesicles (sEV) isolated from colostrum (CM, collected immediately after parturition, n = 8) and transition milk (TM, collected 7 d postpartum, n = 8) from eight 1-yr-old Guanzhong dairy goats with a milk yield of approximately 500 kg/year. A total of 192 unique sEV-associated miRNA (transcripts per million >1 at least 4 samples in either CM or TM) were identified in all samples. There were 29 miRNA uniquely identified in the TM samples while no miRNA was uniquely identified in the CM samples. The abundance of the top 10 miRNA accounted for 82.4% ± 4.0% (± SD) of the total abundance, with let-7 families (e.g., let-7a/b/c-5p) being predominant in all samples. The top 10 miRNA were predicted to target 1,008 unique genes that may regulate pathways such as focal adhesion, TGF-β signaling, and axon guidance. The expression patterns of EV miRNA were similar between the 2 sample groups, although the abundance of let-7c-5p and miR-30a-3p was higher, whereas that of let-7i-5p and miR-103-3p was lower in CM than in TM. In conclusion, the core miRNAome identified in the samples from CM and TM may play an important role in cell proliferation, bone homeostasis, and neuronal network formation in newborn goat kids. The lack of differential miRNA expression between the CM and TM samples may be due to a relatively short sampling interval in which diet composition, intake and health status of ewes, and environment were relatively stable.
Collapse
Affiliation(s)
- T. Ma
- Institute of Feed Research, Key Laboratory of Feed Biotechnology of the Ministry of Agriculture and Rural Affairs, Chinese Academy of Agricultural Sciences, Beijing, 100081, China
| | - Z. Meng
- Inner Mongolia Academy of Agriculture and Animal Husbandry Sciences, Hohhot, 010030, China
| | - M.H. Ghaffari
- Institute of Animal Science, University of Bonn, Bonn, 53115, Germany
| | - J. Lv
- College of Animal Sciences and Technology, Northeast Agricultural University, Harbin, 150030, China
| | - H. Xin
- College of Animal Sciences and Technology, Northeast Agricultural University, Harbin, 150030, China
| | - Q. Zhao
- Inner Mongolia Academy of Agriculture and Animal Husbandry Sciences, Hohhot, 010030, China
| |
Collapse
|
5
|
Xu D, Wei L, Zeng L, Mukiibi R, Xin H, Zhang F. An integrated mRNA-lncRNA signature for overall survival prediction in cholangiocarcinoma. Medicine (Baltimore) 2023; 102:e35348. [PMID: 37773863 PMCID: PMC10545162 DOI: 10.1097/md.0000000000035348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/31/2022] [Accepted: 09/01/2023] [Indexed: 10/01/2023] Open
Abstract
The combination of mRNA and lncRNA profiles for establishing an integrated mRNA-lncRNA prognostic signature has remained unexplored in cholangiocarcinoma (CCA) patients. We utilized a training dataset of 36 samples from The Cancer Genome Atlas dataset and a validation cohort (GSE107943) of 30 samples from Gene Expression Omnibus. Two mRNAs (CFHR3 and PIWIL4) and 2 lncRNAs (AC007285.1 and AC134682.1) were identified to construct the integrated signature through a univariate Cox regression (P-value = 1.35E-02) and a multivariable Cox analysis (P-value = 3.07E-02). Kaplan-Meier curve showed that patients with low risk scores had notably prolonged overall survival than those with high risk scores (P-value = 4.61E-03). Subsequently, the signature was validated in GSE107943 cohort with an area under the curve of 0.750 at 1-year and 0.729 at 3-year. The signature was not only independent from diverse clinical features (P-value = 3.07E-02), but also surpassed other clinical characteristics as prognostic biomarkers with area under the curve of 0.781 at 3-year. Moreover, the weighted gene co-expression network analysis and gene enrichment analyses found that the integrated signature were associated with metabolic-related biological process and lipid metabolism pathway, which has been implicated in the pathogenesis of CCA. Taken together, we developed an integrated mRNA-lncRNA signature that had an independent prognostic value in the risk stratification of patients with CCA.
Collapse
Affiliation(s)
- Derong Xu
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, The Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Lili Wei
- Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - Liping Zeng
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, The Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Robert Mukiibi
- The Roslin Institute, University of Edinburgh, Midlothian, United Kingdom
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, The Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Feng Zhang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, The Institute of Translational Medicine, Nanchang University, Nanchang, China
| |
Collapse
|
6
|
Zhang J, Liu H, Yu Q, Zhan Z, Li T, Shu L, Zhang C, Cheng H, Zhang T, Xin H, Wang X. Hair Derived Microneedle Patches for Both Diabetic Foot Ulcer Prevention and Healing. ACS Biomater Sci Eng 2023; 9:363-374. [PMID: 36564012 DOI: 10.1021/acsbiomaterials.2c01333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
The large amount of reactive oxygen species (ROS) produced by high glucose metabolism in diabetic patients not only induces inflammation but also damages blood vessels, finally resulting in low limb temperature, and the high glucose environment in diabetic patients also makes them susceptible to bacterial infection. Therefore, diabetic foot ulcer (DFU) usually presents as a nonhealing wound. To efficaciously prevent and treat DFU, we proposed a near-infrared (NIR) responsive microneedle (MN) patch hierarchical microparticle (HMP)-ZnO-MN-vascular endothelial growth factor and basic fibroblast growth factor (H-Z-MN-VEGF&bFGF), which could deliver drugs to the limbs painlessly, accurately, and controllably under NIR irradiation. Therein, the hair-derived HMPs exhibited the capacity of scavenging ROS, thereby preventing damage to the blood vessels. Meanwhile, zinc oxide (ZnO) nanoparticles endowed the MN patch with excellent antibacterial activity which could be further enhanced with the photothermal effect of HMPs under NIR irradiation. Moreover, vascular endothelial growth factor and basic fibroblast growth factor could promote the angiogenesis. A series of experiments proved that the MN patch exhibited broad-spectrum antibacterial and anti-inflammatory capacities. In vivo, it obviously increased the temperature of fingertips in diabetic rats as well as promoted collagen deposition and angiogenesis during wound healing. In conclusion, this therapeutic platform provides a promising method for the prevention and treatment of DFU.
Collapse
Affiliation(s)
- Jiao Zhang
- National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi330088, P.R. China
| | - Huijie Liu
- The Affiliated Stomatological Hospital of Nanchang University, The Key Laboratory of Oral Biomedicine, Jiangxi Province Clinical Research Center for Oral Diseases, Nanchang University, Nanchang, Jiangxi330006, P.R. China
| | - Qihang Yu
- College of Chemistry, Nanchang University, Nanchang, Jiangxi330088, P.R. China
| | - Zhenzhen Zhan
- Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi330088, P.R. China
| | - Tong Li
- College of Pharmacy, Nanchang University, Nanchang, Jiangxi330088, P.R. China
| | - Lingxin Shu
- Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi330088, P.R. China
| | - Chuxi Zhang
- Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi330088, P.R. China
| | - Haoxin Cheng
- College of Chemistry, Nanchang University, Nanchang, Jiangxi330088, P.R. China
| | - Teng Zhang
- Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi330088, P.R. China
| | - Hongbo Xin
- National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi330088, P.R. China
| | - Xiaolei Wang
- National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi330088, P.R. China.,College of Chemistry, Nanchang University, Nanchang, Jiangxi330088, P.R. China
| |
Collapse
|
7
|
Liang W, Jiang S, Chai Y, Liu W, L. Liu, Song P, Wang Z, Zhang S, Xin H, Liu X, Xu S, Zhang H, Han Y, Shen W, Peng Z, Geng M, Yu G, Zhang X, He J. 1118P Real-world adjuvant treatment patterns in patients with stage I-III EGFR-mutated non-small cell lung cancer (NSCLC) in China: Interim analysis from the ADDRESS study. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
8
|
Ai Y, He M, Wan C, Luo H, Xin H, Wang Y, Liang Q. Nanoplatform‐Based Reactive Oxygen Species Scavengers for Therapy of Ischemia‐Reperfusion Injury. Advanced Therapeutics 2022. [DOI: 10.1002/adtp.202200066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Yongjian Ai
- MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology Tsinghua University‐Peking University Joint Centre for Life Sciences Beijing Key Lab of Microanalytical Methods & Instrumentation Department of Chemistry Center for Synthetic and Systems Biology Tsinghua University Beijing 100084 P. R. China
| | - Meng‐Qi He
- MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology Tsinghua University‐Peking University Joint Centre for Life Sciences Beijing Key Lab of Microanalytical Methods & Instrumentation Department of Chemistry Center for Synthetic and Systems Biology Tsinghua University Beijing 100084 P. R. China
| | - Chengxian Wan
- Jiangxi Provincial People's Hospital The First Affiliated Hospital of Nanchang Medical College The Affiliated People's Hospital of Nanchang University Nanchang Jiangxi 330006 P. R. China
| | - Hua Luo
- State Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Macau SAR 999078 China
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies Institute of Translational Medicine Nanchang University Nanchang Jiangxi 330088 P. R. China
| | - Yitao Wang
- State Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Macau SAR 999078 China
| | - Qionglin Liang
- MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology Tsinghua University‐Peking University Joint Centre for Life Sciences Beijing Key Lab of Microanalytical Methods & Instrumentation Department of Chemistry Center for Synthetic and Systems Biology Tsinghua University Beijing 100084 P. R. China
| |
Collapse
|
9
|
Deng L, Xu J, Chen W, Guo S, Steiner RD, Chen Q, Cheng Z, Xu Y, Yao B, Li X, Wang X, Deng K, Schrodi SJ, Zhang D, Xin H. Remediation of ABCG5-Linked Macrothrombocytopenia With Ezetimibe Therapy. Front Genet 2021; 12:769699. [PMID: 34880906 PMCID: PMC8645579 DOI: 10.3389/fgene.2021.769699] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2021] [Accepted: 10/21/2021] [Indexed: 11/29/2022] Open
Abstract
To investigate refractory hypercholesterolemia, a female patient and relatives were subjected to whole-genome sequencing. The proband was found to have compound heterozygous substitutions p. Arg446Gln and c.1118+3G>T in ABCG5, one of two genes causing sitosterolemia. When tracing these variants in the full pedigree, all maternally related heterozygotes for the intronic ABCG5 variant exhibited large platelets (over 30 fl), which segregated in an autosomal dominant manner, consistent with macrothrombocytopenia, or large platelet syndrome which may be associated with a bleeding tendency. In vitro cell-line and in vivo rat model experiments supported a pathogenic role for the variant and the macrothrombocytopenia was recapitulated in heterozygous rats and human cell lines exhibiting that single variant. Ezetimibe treatment successfully ameliorated all the symptoms of the proband with sitosterolemia and resolved the macrothrombocytopenia of the treated heterozygote relatives. Subsequently, in follow up these observations, platelet size, and size distribution were measured in 1,180 individuals; 30 were found to be clinically abnormal, three of which carried a single known pathogenic ABCG5 variant (p.Arg446Ter) and two individuals carried novel ABCG5 variants of uncertain significance. In this study, we discovered that identification of large platelets and therefore a possible macrothrombocytopenia diagnosis could easily be inadvertently missed in clinical practice due to variable instrument settings. These findings suggest that ABCG5 heterozygosity may cause macrothrombocytopenia, that Ezetimibe treatment may resolve macrothrombocytopenia in such individuals, and that increased attention to platelet size on complete blood counts can aid in the identification of candidates for ABCG5 genetic testing who might benefit from Ezetimibe treatment.
Collapse
Affiliation(s)
- Libin Deng
- The Second Affiliated Hospital of Nanchang University, Nanchang, China.,Institute of Translational Medicine, Nanchang University, Nanchang, China.,Jiangxi Provincial Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University, Nanchang, China
| | - Jingsong Xu
- The Second Affiliated Hospital of Nanchang University, Nanchang, China
| | - Wei Chen
- Key Laboratory of Biomechanics and Mechanobiology, Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing, China
| | - Shicheng Guo
- Department of Medical Genetics, University of Wisconsin-Madison, Madison, WI, United States
| | - Robert D Steiner
- Department of Pediatrics, University of Wisconsin-Madison, Madison, WI, United States
| | - Qi Chen
- The Second Affiliated Hospital of Nanchang University, Nanchang, China
| | - Zhujun Cheng
- Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Yanmei Xu
- The Second Affiliated Hospital of Nanchang University, Nanchang, China
| | - Bei Yao
- Department of Clinical Laboratory, Peking University Third Hospital, Beijing, China
| | - Xiaoyan Li
- Beijing Institute of Heart, Lung & Blood Vessel Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
| | - Xiaozhong Wang
- The Second Affiliated Hospital of Nanchang University, Nanchang, China
| | - Keyu Deng
- Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Steven J Schrodi
- Department of Medical Genetics, University of Wisconsin-Madison, Madison, WI, United States
| | - Dake Zhang
- Key Laboratory of Biomechanics and Mechanobiology, Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing, China
| | - Hongbo Xin
- Institute of Translational Medicine, Nanchang University, Nanchang, China
| |
Collapse
|
10
|
Dong K, Shen J, He X, Hu G, Wang L, Osman I, Bunting KM, Dixon-Melvin R, Zheng Z, Xin H, Xiang M, Vazdarjanova A, Fulton DJR, Zhou J. CARMN Is an Evolutionarily Conserved Smooth Muscle Cell-Specific LncRNA That Maintains Contractile Phenotype by Binding Myocardin. Circulation 2021; 144:1856-1875. [PMID: 34694145 PMCID: PMC8726016 DOI: 10.1161/circulationaha.121.055949] [Citation(s) in RCA: 38] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Vascular homeostasis is maintained by the differentiated phenotype of vascular smooth muscle cells (VSMCs). The landscape of protein coding genes comprising the transcriptome of differentiated VSMCs has been intensively investigated but many gaps remain including the emerging roles of noncoding genes. METHODS We reanalyzed large-scale, publicly available bulk and single-cell RNA sequencing datasets from multiple tissues and cell types to identify VSMC-enriched long noncoding RNAs. The in vivo expression pattern of a novel smooth muscle cell (SMC)-expressed long noncoding RNA, Carmn (cardiac mesoderm enhancer-associated noncoding RNA), was investigated using a novel Carmn green fluorescent protein knock-in reporter mouse model. Bioinformatics and quantitative real-time polymerase chain reaction analysis were used to assess CARMN expression changes during VSMC phenotypic modulation in human and murine vascular disease models. In vitro, functional assays were performed by knocking down CARMN with antisense oligonucleotides and overexpressing Carmn by adenovirus in human coronary artery SMCs. Carotid artery injury was performed in SMC-specific Carmn knockout mice to assess neointima formation and the therapeutic potential of reversing CARMN loss was tested in a rat carotid artery balloon injury model. The molecular mechanisms underlying CARMN function were investigated using RNA pull-down, RNA immunoprecipitation, and luciferase reporter assays. RESULTS We identified CARMN, which was initially annotated as the host gene of the MIR143/145 cluster and recently reported to play a role in cardiac differentiation, as a highly abundant and conserved, SMC-specific long noncoding RNA. Analysis of the Carmn GFP knock-in mouse model confirmed that Carmn is transiently expressed in embryonic cardiomyocytes and thereafter becomes restricted to SMCs. We also found that Carmn is transcribed independently of Mir143/145. CARMN expression is dramatically decreased by vascular disease in humans and murine models and regulates the contractile phenotype of VSMCs in vitro. In vivo, SMC-specific deletion of Carmn significantly exacerbated, whereas overexpression of Carmn markedly attenuated, injury-induced neointima formation in mouse and rat, respectively. Mechanistically, we found that Carmn physically binds to the key transcriptional cofactor myocardin, facilitating its activity and thereby maintaining the contractile phenotype of VSMCs. CONCLUSIONS CARMN is an evolutionarily conserved SMC-specific long noncoding RNA with a previously unappreciated role in maintaining the contractile phenotype of VSMCs and is the first noncoding RNA discovered to interact with myocardin.
Collapse
Affiliation(s)
- Kunzhe Dong
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia, 30912, USA
| | - Jian Shen
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia, 30912, USA
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, 310009, China
| | - Xiangqin He
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia, 30912, USA
| | - Guoqing Hu
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia, 30912, USA
| | - Liang Wang
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia, 30912, USA
- Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
| | - Islam Osman
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia, 30912, USA
| | - Kristopher M. Bunting
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia, 30912, USA
| | - Rachael Dixon-Melvin
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia, 30912, USA
| | - Zeqi Zheng
- Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330031, China
- School of Life Sciences, Nanchang University, Nanchang, Jiangxi, 330031, China
| | - Meixiang Xiang
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, 310009, China
| | - Almira Vazdarjanova
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia, 30912, USA
| | - David J. R. Fulton
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia, 30912, USA
- Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, Georgia, 30912, USA
| | - Jiliang Zhou
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia, 30912, USA
| |
Collapse
|
11
|
Zhang C, Jia S, Huang J, Peng H, Zhang J, Liu L, Zhang W, Xin H, Wang X. A carbonized wormwood modified photothermal microneedle patch for the repair of damaged skeletal muscles. J Mater Chem B 2021; 9:8014-8020. [PMID: 34477628 DOI: 10.1039/d1tb00610j] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
In this study, we aimed to achieve an efficient repair of damaged skeletal muscles using polyvinyl alcohol (PVA) soluble microneedle patches (MNP) loaded with carbonized wormwood and prostaglandin E2 (inflammatory factors). The introduction of carbonized wormwood imparted the MNP with near-infrared light heating characteristics that improved the efficiency of prostaglandin E2 delivery while also promoting circulation in the damaged muscle area. Our experimental results showed that, compared with the classical moxibustion treatment, the system could more quickly restore muscle strength and the cross-sectional area of muscle bundle fibers in a mouse model of muscular injury. In addition, it could also successfully induce the proliferation and differentiation of muscle stem cells to effectively repair injured muscle tissues. Above all, this light-controlled photothermal MN (microneedle) drug-delivery system avoided the common problems of traditional moxibustion such as large levels of smoke, slow efficacy and risk of scalding. Collectively, we put forward a safe, accurate and efficient approach for skeletal muscle damage treatment using carbonized wormwood.
Collapse
Affiliation(s)
- Chuxi Zhang
- The First Clinical Medical College, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Shuang Jia
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China.
| | - Jinlong Huang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China.
| | - Haichuan Peng
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China.
| | - Jiao Zhang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China.
| | - Lubing Liu
- The First Clinical Medical College, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Wei Zhang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China.
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China.
| | - Xiaolei Wang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China. .,College of Chemistry, Nanchang University, Nanchang, Jiangxi 330088, China
| |
Collapse
|
12
|
Jin L, Wang Y, Ouyang H, Liu Y, Zhu Z, Wang S, Xin H, Wang X. A versatile and low-toxicity material for photothermal therapy in deeper tissues. J Mater Chem B 2021; 9:6155-6162. [PMID: 34318782 DOI: 10.1039/d0tb03000g] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The limited depth of the near infrared (NIR) response is one of the major flaws of the present photothermal therapy (PTT). In this article, thermosensitive polyurethane urea (TPUU) was synthesized by polymerization. Subsequent experiments showed that, compared with classical photosensitizers, TPUU has higher photothermal effects and lower cytotoxicity. These valuable properties could make the present PTT research provide more therapeutic options among different tissues and organs. As a practical example, TPUU was applied to regulate the intestinal flora through external NIR irradiation, which implied its promising expanded applications in deeper tissues.
Collapse
Affiliation(s)
- Liguo Jin
- College of Chemistry, Nanchang University, Nanchang, Jiangxi 330088, China.
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Gan L, Liu D, Liu J, Chen E, Chen C, Liu L, Hu H, Guan X, Ma W, Zhang Y, He Y, Liu B, Tang S, Jiang W, Xue J, Xin H. CD38 deficiency alleviates Ang II-induced vascular remodeling by inhibiting small extracellular vesicle-mediated vascular smooth muscle cell senescence in mice. Signal Transduct Target Ther 2021; 6:223. [PMID: 34112762 PMCID: PMC8192533 DOI: 10.1038/s41392-021-00625-0] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2020] [Revised: 03/29/2021] [Accepted: 04/27/2021] [Indexed: 02/05/2023] Open
Abstract
CD38 is the main enzyme for nicotinamide adenine dinucleotide (NAD) degradation in mammalian cells. Decreased NAD levels are closely related to metabolic syndromes and aging-related diseases. Our study showed that CD38 deficiency significantly alleviated angiotensin II (Ang II)-induced vascular remodeling in mice, as shown by decreased blood pressures; reduced vascular media thickness, media-to-lumen ratio, and collagen deposition; and restored elastin expression. However, our bone marrow transplantation assay showed that CD38 deficiency in lymphocytes led to lack of protection against Ang II-induced vascular remodeling, suggesting that the effects of CD38 on Ang II-induced vascular remodeling might rely primarily on vascular smooth muscle cells (VSMCs), not lymphocytes. In addition, we observed that CD38 deficiency or NAD supplementation remarkably mitigated Ang II-induced vascular senescence by suppressing the biogenesis, secretion, and internalization of senescence-associated small extracellular vesicles (SA-sEVs), which facilitated the senescence of neighboring non-damaged VSMCs. Furthermore, we found that the protective effects of CD38 deficiency on VSMC senescence were related to restoration of lysosome dysfunction, particularly with respect to the maintenance of sirtuin-mediated mitochondrial homeostasis and activation of the mitochondria-lysosomal axis in VSMCs. In conclusion, our findings demonstrated that CD38 and its associated intracellular NAD decline are critical for Ang II-induced VSMC senescence and vascular remodeling.
Collapse
Affiliation(s)
- Lu Gan
- Research Laboratory of Emergency Medicine, Department of Emergency Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
| | - Demin Liu
- Cardiology Department, The Second Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China
| | - Jing Liu
- Department of Endocrinology, The Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China
| | - Erya Chen
- Department of Anesthesiology, Laboratory of Anesthesia and Critical Care Medicine, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China
| | - Chan Chen
- Department of Anesthesiology, Laboratory of Anesthesia and Critical Care Medicine, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China
| | - Lian Liu
- Research Laboratory of Emergency Medicine, Department of Emergency Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, People's Republic of China
| | - Hang Hu
- Research Laboratory of Emergency Medicine, Department of Emergency Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, People's Republic of China
| | - Xiaohui Guan
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, People's Republic of China
| | - Wen Ma
- Research Laboratory of Emergency Medicine, Department of Emergency Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, People's Republic of China
| | - Yanzi Zhang
- Research Laboratory of Emergency Medicine, Department of Emergency Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, People's Republic of China
| | - Yarong He
- Research Laboratory of Emergency Medicine, Department of Emergency Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, People's Republic of China
| | - Bofu Liu
- Research Laboratory of Emergency Medicine, Department of Emergency Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, People's Republic of China
| | - Songling Tang
- Research Laboratory of Emergency Medicine, Department of Emergency Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, People's Republic of China
| | - Wei Jiang
- State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People's Republic of China
| | - Jianxin Xue
- State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
- Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, People's Republic of China.
| |
Collapse
|
14
|
Zhang Y, Liu Y, Zhang T, Wang Q, Huang L, Zhong Z, Lin J, Hu K, Xin H, Wang X. Targeted Thrombolytic Therapy with Metal-Organic-Framework-Derived Carbon Based Platforms with Multimodal Capabilities. ACS Appl Mater Interfaces 2021; 13:24453-24462. [PMID: 34008940 DOI: 10.1021/acsami.1c03134] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
A dual-response (near-infrared, alternating magnetic field) multifunctional nanoplatform was developed based on urokinase plasminogen activators (uPA)-loaded metal-organic-framework (MOF)-derived carbon nanomaterials (referred to uPA@CFs below) for thrombolytic therapy. uPA loaded in mesoporous CFs could be released under the action of near-infrared (NIR)-mediated photothermy to achieve superficial thrombolysis. More importantly, with the assistance of alternating magnetic field (AMF), this system could also precisely heat the thrombosis in the deep tissue area. Quantitative experiments proved that the thrombolytic efficiency of this dual-response system at deep venous thrombosis was nearly 6 times than that of NIR alone. This is the first application that MOF-derived carbon nanomaterials in the field of targeted thrombolysis. To our delight, the MOF-derived carbon nanomaterials (CFs) not only maintained the drug-carrying capacity, but also endowed CFs with reliable magnetic targeting ability. More encouragingly, the CFs also showed extraordinary angiogenic performance, thus opening up the prospect of its clinical application.
Collapse
Affiliation(s)
- Yini Zhang
- the National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, P.R. China
| | - Yu Liu
- College of Mechanical & Electronic Engineering, Nanchang University, Nanchang, Jiangxi 330088, P.R. China
| | - Teng Zhang
- The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330000, P.R. China
| | - Qingqing Wang
- the National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, P.R. China
| | - Ling Huang
- the National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, P.R. China
| | - Zhiwei Zhong
- The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330000, P.R. China
| | - Jiarui Lin
- the National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, P.R. China
| | - Kaigeng Hu
- the National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, P.R. China
| | - Hongbo Xin
- the National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, P.R. China
| | - Xiaolei Wang
- the National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, P.R. China
- College of Chemistry, Nanchang University, Nanchang, Jiangxi 330088, P.R. China
| |
Collapse
|
15
|
Jin L, Cheng H, Xie X, Chen X, Tian G, Zhu Z, Wang S, Xin H, Wang X. Dual-Effective Chronic Wounds Management System through a Monoglyceride Binary Blend Matrix Based Thermal-Responsive Phase-Transition Substrate. Adv Healthc Mater 2021; 10:e2001966. [PMID: 33496389 DOI: 10.1002/adhm.202001966] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Revised: 12/21/2020] [Indexed: 12/21/2022]
Abstract
A new monoglyceride-based heat-sensitive substrate is proposed, for the first time, as a wound management system. First, an appropriate portion of glyceryl monooleate (GMO) and glyceryl monostearate (GMS) is mixed to provide a thermal phase responsive matrix (GMO-GMS, GG). Subsequently, to improve the photothermal responsive and antibacterial performance, silver nanoparticles (Ag) decorated reduced graphene oxide (rGO) nanocomposite (rGO-Ag) is added to the GG matrix to obtain (GG-rGO-Ag). According to the systematic studies from uninfected, infected, and diabetic wound models, by applying near infrared (NIR) laser, the phase change of GG-rGO-Ag can be triggered to release Ag on demand for sterilization. More importantly, this smart GG substrate can also promote the production of vascular endothelial growth factor protein, thus serving as a NIR defined mufti-effective wound management system.
Collapse
Affiliation(s)
- Liguo Jin
- College of Chemistry Nanchang University Nanchang Jiangxi 330088 China
- The National Engineering Research Center for Bioengineering Drugs and the Technologies: Institute of Translational Medicine Nanchang University Nanchang Jiangxi 330088 China
| | - Haoxin Cheng
- College of Chemistry Nanchang University Nanchang Jiangxi 330088 China
| | - Xuanping Xie
- The National Engineering Research Center for Bioengineering Drugs and the Technologies: Institute of Translational Medicine Nanchang University Nanchang Jiangxi 330088 China
| | - Xinyu Chen
- College of Chemistry Nanchang University Nanchang Jiangxi 330088 China
| | - Guangqi Tian
- The National Engineering Research Center for Bioengineering Drugs and the Technologies: Institute of Translational Medicine Nanchang University Nanchang Jiangxi 330088 China
| | - Zhenling Zhu
- College of Chemistry Nanchang University Nanchang Jiangxi 330088 China
| | - Shuhua Wang
- College of Chemistry Nanchang University Nanchang Jiangxi 330088 China
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies: Institute of Translational Medicine Nanchang University Nanchang Jiangxi 330088 China
| | - Xiaolei Wang
- College of Chemistry Nanchang University Nanchang Jiangxi 330088 China
- The National Engineering Research Center for Bioengineering Drugs and the Technologies: Institute of Translational Medicine Nanchang University Nanchang Jiangxi 330088 China
| |
Collapse
|
16
|
Xia C, Jiang C, Li W, Wei J, Hong H, Li J, Feng L, Wei H, Xin H, Chen T. A Phase II Randomized Clinical Trial and Mechanistic Studies Using Improved Probiotics to Prevent Oral Mucositis Induced by Concurrent Radiotherapy and Chemotherapy in Nasopharyngeal Carcinoma. Front Immunol 2021; 12:618150. [PMID: 33841399 PMCID: PMC8024544 DOI: 10.3389/fimmu.2021.618150] [Citation(s) in RCA: 47] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2020] [Accepted: 02/10/2021] [Indexed: 12/11/2022] Open
Abstract
Earlier evidence has proven that probiotic supplements can reduce concurrent chemoradiotherapy (CCRT)-induced oral mucositis (OM) in nasopharyngeal cancer (NPC). The incidence of severe OM (grade 3 or higher) was the primary endpoint in this study. We first enrolled 85 patients with locally advanced NPC who were undergoing CCRT. Of them, 77 patients were finally selected and randomized (1:1) to receive either a probiotic cocktail or placebo. To investigate the protective effects and the mechanism of probiotic cocktail treatment on OM induced by radiotherapy and chemotherapy, we randomly divided the rats into the control (C) group, the model (M) group, and the probiotic (P) group. After treatment, samples from the tongue, blood, and fecal and proximal colon tissues on various days (7th, 14th, and 21st days) were collected and tested for the inflammatory response, cell apoptosis, intestinal permeability, and intestinal microbial changes. We found that patients taking the probiotic cocktail showed significantly lower OM. The values of the incidence of 0, 1, 2, 3, and 4 grades of OM in the placebo group and in the probiotic cocktail group were reported to be 0, 14.7, 38.2, 32.4, and 14.7% and 13.9, 36.1, 25, 22.2, and 2.8%, respectively. Furthermore, patients in the probiotic cocktail group showed a decrease in the reduction rate of CD3+ T cells (75.5% vs. 81%, p < 0.01), CD4+ T cells (64.53% vs. 79.53%, p < 0.01), and CD8+ T cells (75.59 vs. 62.36%, p < 0.01) compared to the placebo group. In the rat model, the probiotic cocktail could ameliorate the severity of OM, decrease the inflammatory response, cause cell apoptosis and intestinal permeability, and restore the structure of gut microbiota to normalcy. In conclusion, the modified probiotic cocktail significantly reduces the severity of OM by enhancing the immune response of patients with NPC and modifying the structure of gut microbiota. Clinical Trial Registration: The Clinical Trial Registration should be the NCT03112837.
Collapse
Affiliation(s)
- Chaofei Xia
- National Engineering Research Center for Bioengineering Drugs and Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Chunling Jiang
- Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, China.,NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital of Nanchang University), Nanchang, China
| | - Wenyu Li
- National Engineering Research Center for Bioengineering Drugs and Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Jing Wei
- National Engineering Research Center for Bioengineering Drugs and Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Hu Hong
- National Engineering Research Center for Bioengineering Drugs and Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Jingao Li
- Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, China.,NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital of Nanchang University), Nanchang, China
| | - Liu Feng
- Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, China.,NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital of Nanchang University), Nanchang, China
| | - Hong Wei
- Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
| | - Hongbo Xin
- National Engineering Research Center for Bioengineering Drugs and Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Tingtao Chen
- National Engineering Research Center for Bioengineering Drugs and Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| |
Collapse
|
17
|
Huang L, Xiang J, Cheng Y, Xiao L, Wang Q, Zhang Y, Xu T, Chen Q, Xin H, Wang X. Regulation of Blood Glucose Using Islets Encapsulated in a Melanin-Modified Immune-Shielding Hydrogel. ACS Appl Mater Interfaces 2021; 13:12877-12887. [PMID: 33689267 DOI: 10.1021/acsami.0c23010] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Islet transplantation is currently a promising treatment for type 1 diabetes mellitus. However, the foreign body reaction and retrieval difficulty often lead to transplantation failure and hinder the clinical application. To address these two challenges, we propose a balanced charged sodium alginate-polyethyleneimine-melanin (SA-PEI-Melanin) threadlike hydrogel with immune shielding and retrievable properties. The attractiveness of this study lies in that the introduction of melanin can stimulate insulin secretion, especially under near-infrared (NIR) irradiation. After demonstrating a good immune-shielding effect, we performed an in vivo transplantation experiment. The results showed that the blood glucose level in the SA-PEI-Melanin group was stably controlled below the diabetic blood glucose criterion, and this blood glucose level could be further adjusted after NIR irradiation. In addition, the evaluation after retrieving the SA-PEI-Melanin hydrogel indicated that the islets still maintained a normal physiological function, further proving its excellent immunological protection. This study provides a new approach for the accurate regulation of blood glucose in patients with type 1 diabetes mellitus and contributes to developing a promising transplant system to reconcile real-time and precise light-defined insulin secretion regulation.
Collapse
Affiliation(s)
- Ling Huang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, P. R. China
| | - Jiajia Xiang
- College of Pharmacy, Nanchang University, Nanchang, Jiangxi 330006, P. R. China
| | - Yukai Cheng
- College of Pharmacy, Nanchang University, Nanchang, Jiangxi 330006, P. R. China
| | - Ling Xiao
- College of Pharmacy, Nanchang University, Nanchang, Jiangxi 330006, P. R. China
| | - Qingqing Wang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, P. R. China
| | - Yini Zhang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, P. R. China
| | - Tieling Xu
- College of Pharmacy, Nanchang University, Nanchang, Jiangxi 330006, P. R. China
| | - Qianrui Chen
- College of Pharmacy, Nanchang University, Nanchang, Jiangxi 330006, P. R. China
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, P. R. China
| | - Xiaolei Wang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, P. R. China
- College of Chemistry, Nanchang University, Nanchang, Jiangxi 330088, P. R. China
| |
Collapse
|
18
|
Wang L, Chen T, Wang H, Wu X, Cao Q, Wen K, Deng KY, Xin H. Engineered Bacteria of MG1363-pMG36e-GLP-1 Attenuated Obesity-Induced by High Fat Diet in Mice. Front Cell Infect Microbiol 2021; 11:595575. [PMID: 33732656 PMCID: PMC7959774 DOI: 10.3389/fcimb.2021.595575] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2020] [Accepted: 01/19/2021] [Indexed: 12/12/2022] Open
Abstract
Background Although gut hormone glucagon-like peptide 1 (GLP-1) has been widely used for treating diabetes, the extremely short half-life greatly limits its application. The purpose of this study is to explore the effects of an engineered bacteria with expression of GLP-1 on obese mice induced by high fat diet (HFD). Methods The engineered strain of MG1363-pMG36e-GLP-1 (M-GLP-1) was constructed and its anti-obesity effects were evaluated in vivo. The bodyweight, the morphology of adipose and liver tissue, and liver function were examined. Quantitative RT-PCR and Western blot were used to measure the expressions of the genes involved in fatty acid oxidation synthesis. The intestinal microbial diversity was detected with high-throughput sequencing analysis. Results The engineered bacteria could produce GLP-1. It also significantly decreased the bodyweight and improved the glucose intolerance in the obese mice induced by HFD. Moreover, the strain also reduced the triglyceride (TG) in serum, protected liver, as well as decreased the intracellular TG in liver tissues of the obese mice. Furthermore, our results showed that the expressions of the genes including peroxisome proliferator-activated receptors α (PPARα) and its target genes were enhanced in liver tissues when mice treated with M-GLP-1. Finally, we found that the engineered strain markedly increased intestinal microbial diversity. Conclusion Our results suggested the genetically engineered bacteria that constitutively secreted GLP-1 could improve obesity and the mechanism may be related to promoting fatty acid oxidation and increasing intestinal microbial diversity of the obese mice.
Collapse
Affiliation(s)
- Lingfang Wang
- National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Tingtao Chen
- National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Huan Wang
- National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Xiaoli Wu
- College of Basic Medicine, JiangXi University of Traditional Chinese Medicine, Nanchang, China
| | - Qing Cao
- National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Ke Wen
- National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Ke-Yu Deng
- National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Hongbo Xin
- National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| |
Collapse
|
19
|
Wang M, Cheng X, Luo L, Liu Y, Cao F, Zhao S, Peng H, Hong C, Jin L, Deng L, Xin H, Wang X. A multi-effective and long-acting immunotherapy through one single hydrogel based injection. Biomater Sci 2021; 9:1374-1380. [PMID: 33367315 DOI: 10.1039/d0bm01974g] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A dual-effective (photothermal and immune) therapy employing gold nanorods (AuNRs) with a drug (two macrophage migration inhibitory factor (MIF) inhibitors) sustained release hydrogel was designed in this paper. The subsequent cellular and animal studies demonstrated that the proposed therapy can not only inhibit the proliferation, migration, and recurrence of cancer cells, but also improve the immune function (increase the infiltration of CD8+ killer T cells in tumors) without the traditional multiple injections of expensive immune drugs.
Collapse
Affiliation(s)
- Manyu Wang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Ding L, Fang Y, Li Y, Hu Q, Ai M, Deng K, Huang X, Xin H. AIMP3 inhibits cell growth and metastasis of lung adenocarcinoma through activating a miR-96-5p-AIMP3-p53 axis. J Cell Mol Med 2021; 25:3019-3030. [PMID: 33538115 PMCID: PMC7957209 DOI: 10.1111/jcmm.16344] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2020] [Revised: 12/24/2020] [Accepted: 01/15/2021] [Indexed: 12/18/2022] Open
Abstract
Aminoacyl‐tRNA synthetase‐interacting multifunctional protein‐3 (AIMP3) is a tumour suppressor, however, the roles of AIMP3 in non‐small cell lung cancer (NSCLC) are not explored yet. Here, we reported that AIMP3 significantly inhibited the cell growth and metastasis of NSCLC (lung adenocarcinoma) in vitro and in vivo. We have firstly identified that AIMP3 was down‐regulated in human NSCLC tissues compared with adjacent normal lung tissues using immunohistochemistry and western blot assays. Overexpression of AIMP3 markedly suppressed the proliferation and migration of cancer cells in a p53‐dependent manner. Furthermore, we observed that AIMP3 significantly suppressed tumour growth and metastasis of A549 cells in xenograft nude mice. Mechanically, we identified that AIMP3 was a direct target of miR‐96‐5p, and we also observed that there was a negative correlation between AIMP3 and miR‐96‐5p expression in paired NSCLC clinic samples. Ectopic miR‐96‐5p expression promoted the proliferation and migration of cancer cells in vitro and tumour growth and metastasis in vivo which partially depended on AIMP3. Taken together, our results demonstrated that the axis of miR‐96‐5p‐AIMP3‐p53 played an important role in lung adenocarcinoma, which may provide a new strategy for the diagnosis and treatment of NSCLC.
Collapse
Affiliation(s)
- Liting Ding
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, the Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Yang Fang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, the Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Yong Li
- Department of Anesthesiology, the First Affiliated Hospital of Nanchang University, Nanchang, China
| | - Qinghua Hu
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, the Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Meiling Ai
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, the Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Keyu Deng
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, the Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Xuan Huang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, the Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, the Institute of Translational Medicine, Nanchang University, Nanchang, China
| |
Collapse
|
21
|
Peng H, Zhou Y, Zhang C, Wang M, Zhao S, Xu Y, Zhang W, Xin H, Wang X. An accurate and dual-effective body slimming method through a soluble microneedle patch with variable temperature. J Mater Chem B 2021; 9:421-427. [PMID: 33367393 DOI: 10.1039/d0tb01547d] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Obesity is a chronic and recurrent disease with potential risks. Traditional weight-loss methods (like exercises, surgeries, oral drugs, etc.) have shown different side effects. In this experiment, the microneedle (MN) patch was selected as the drug carrier of the weight-loss drug Rosiglitazone (Rosi). Besides, melanin was added to enhance the photo-thermal effect and accelerate the release of drugs to the target fat region under near-infrared (NIR) light. Afterwards, with exterior cold stimulation, the significant and accurate effect of body slimming could be achieved. This combination of soluble MN patches and variable temperatures provides an attractive nonsurgical method for future accurate body slimming management.
Collapse
Affiliation(s)
- Haichuan Peng
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China.
| | - Yan Zhou
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China.
| | - Chuxi Zhang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China.
| | - Manyu Wang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China.
| | - Siyu Zhao
- The Key Laboratory of Oral Biomedicine, The Affiliated Stomatological Hospital of Nanchang University, Nanchang, Jiangxi 330006, China
| | - Yingying Xu
- The Key Laboratory of Oral Biomedicine, The Affiliated Stomatological Hospital of Nanchang University, Nanchang, Jiangxi 330006, China
| | - Wei Zhang
- College of Chemistry, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China.
| | - Xiaolei Wang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China. and College of Chemistry, Nanchang University, Nanchang, Jiangxi 330088, China
| |
Collapse
|
22
|
Zhang F, Zeng L, Cai Q, Xu Z, Liu R, Zhong H, Mukiibi R, Deng L, Tang X, Xin H. Comprehensive Analysis of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Wilms Tumor. Cancer Control 2021; 27:1073274820936991. [PMID: 32597194 PMCID: PMC7324900 DOI: 10.1177/1073274820936991] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
Long noncoding RNA (lncRNA) plays crucial roles in various biological processes of different cancers, especially acting as a competing endogenous RNA (ceRNA). However, the role of lncRNA-mediated ceRNA in Wilms tumor (WT), which is the most common malignant kidney cancer in children, remains unknown. In present study, RNA sequence profiles and clinical data of 125 patients with WT consisting of 119 tumor and 6 normal tissues from Therapeutically Applicable Research To Generate Effective Treatments database were analyzed. A total of 1833 lncRNAs, 156 microRNAs (miRNAs), and 3443 messenger RNAs (mRNAs) were identified as differentially expressed (DE) using "DESeq2" package. The lncRNA-miRNA-mRNA ceRNA regulatory network involving 748 DElncRNAs, 33 DEmiRNAs, and 189 DEmRNAs was constructed based on miRcode, Targetscan, miRTarBase, and miRDB database. Gene Ontology term and Kyoto Encyclopedia of Genes and Genomes pathway analyses revealed that DEmRNAs were mainly enriched in cell proliferation-related processes and tumor-related pathways, respectively, and 13 hub genes were identified by a protein-protein interaction network. Survival analysis detected 48 lncRNAs, 7 miRNAs, and 16 mRNAs to have significant impact on the overall survival of patients with WT. Additionally, we found that 6 DElncRNAs with potential prognostic value were correlated with tumor stage (DENND5B-AS1) and histologic classification (TMPO-AS1, RP3-523K23.2, RP11-598F7.3, LAMP5-AS1, and AC013275.2) of patients with WT. Our research provides a great insight into understanding the molecular mechanism underlying occurrence and progression of WT, as well as the potential to develop targeted therapies and prognostic biomarkers.
Collapse
Affiliation(s)
- Feng Zhang
- Nanchang University, Nanchang, China.,The National Engineering Research Center for Bioengineering Drugs and the Technologies, The Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Liping Zeng
- Nanchang University, Nanchang, China.,The National Engineering Research Center for Bioengineering Drugs and the Technologies, The Institute of Translational Medicine, Nanchang University, Nanchang, China
| | | | - Zihao Xu
- Nanchang University, Nanchang, China
| | - Ruida Liu
- Nanchang University, Nanchang, China
| | | | - Robert Mukiibi
- Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada
| | - Libin Deng
- Nanchang University, Nanchang, China.,The National Engineering Research Center for Bioengineering Drugs and the Technologies, The Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Xiaoli Tang
- Nanchang University, Nanchang, China.,Department of Biochemistry, School of Medicine, Nanchang University, Nanchang, China
| | - Hongbo Xin
- Nanchang University, Nanchang, China.,The National Engineering Research Center for Bioengineering Drugs and the Technologies, The Institute of Translational Medicine, Nanchang University, Nanchang, China
| |
Collapse
|
23
|
Zhang H, Cao X, Wang D, Xin H, Liu Z, Yan J, Feng B, Quan Z, Du Y, Liu J, Guan L, Shen F, Guan X, Jin Q, Pan S, Gao L. The acquisition of Mycobacterium tuberculosis infection in village doctors in China: a prospective study. Int J Tuberc Lung Dis 2020; 24:1241-1246. [PMID: 33317666 DOI: 10.5588/ijtld.20.0153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND: Occupational exposure-related risk of Mycobacterium tuberculosis infection has been reported for village doctors in China. This prospective study aims to estimate the infection acquisition in this key population.METHODS: At baseline, all village doctors registered in Zhongmu County were tested by QuantiFERON®-TB Gold In-Tube (QFT) and QuantiFERON®-TB Gold Plus (QFT-Plus) in parallel. Those negatives for either of the tests were retested to identify conversions at the 2-year follow-up investigation.RESULTS: A total of 367 eligible participants completed the 2-year follow-up survey with frequency of conversion of 5.0% (18/361) for QFT and 6.1% (21/343) for QFT-Plus. The agreement of follow-up results between the tests was 93.2% with a κ coefficient of 0.43 (95%CI 0.20-0.65). Among QFT-Plus convertors, the difference between TB1 and TB2 tubes (TB2-TB1) was significantly increased as compared with baseline results (P = 0.039). Participants from the villages with occurrence of microbiologically confirmed pulmonary TB showed higher frequency of QFT conversions (11.0% vs. 3.2%, P = 0.011) and QFT-Plus conversions (12.3% vs. 4.4%, P = 0.027) than those from the villages without occurrence.CONCLUSION: Our results consistently suggest that capability on occupational protection and M. tuberculosis infection control should be improved in village doctors in China.
Collapse
Affiliation(s)
- H Zhang
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
| | - X Cao
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
| | - D Wang
- Center for Disease Prevention and Control of Zhongmu County, Zhengzhou
| | - H Xin
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
| | - Z Liu
- Center for Disease Prevention and Control of Zhongmu County, Zhengzhou
| | - J Yan
- Center for Disease Prevention and Control of Zhongmu County, Zhengzhou
| | - B Feng
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
| | - Z Quan
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
| | - Y Du
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
| | - J Liu
- The Sixth People´s Hospital of Zhengzhou, Zhengzhou, China
| | - L Guan
- The Sixth People´s Hospital of Zhengzhou, Zhengzhou, China
| | - F Shen
- The Sixth People´s Hospital of Zhengzhou, Zhengzhou, China
| | - X Guan
- The Sixth People´s Hospital of Zhengzhou, Zhengzhou, China
| | - Q Jin
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
| | - S Pan
- Center for Disease Prevention and Control of Zhongmu County, Zhengzhou
| | - L Gao
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
| |
Collapse
|
24
|
Wu C, Zhang Z, Zhou K, Chen W, Tao J, Li C, Xin H, Song Y, Ai F. Preparation and characterization of borosilicate-bioglass-incorporated sodium alginate composite wound dressing for accelerated full-thickness skin wound healing. Biomed Mater 2020; 15:055009. [PMID: 32422624 DOI: 10.1088/1748-605x/ab9421] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Full-thickness skin injury is a serious and intractable clinical problem. Wound dressing is urgently needed to treat serious skin defects or induce skin reconstruction. For the first time, we demonstrated a borosilicate bioglass (BBG)-incorporated sodium alginate (SA) wound dressing by a simple and effective technique for accelerated wound healing. The physical and chemical properties, in vitro and in vivo properties of SA-BBG composite wound dressing have been investigated. The results show that the SA-BBG composite dressing possesses good water absorption performance. The boron and silicon ions in BBG can maintain stable and sustained release. Most importantly, the SA-BBG composite wound dressing shows outstanding wound healing ability in full-thickness skin defects in rats. The wounds treated with SA-BBG composite dressing groups had almost closed at day 15. When the ratio of sodium alginate to bioglass in the sponge is 3:1, the wound healing effect is the best. In conclusion, the SA-BBG composite dressing shows great potential for application in skin wound healing and SA3BBG works best.
Collapse
Affiliation(s)
- Chunxuan Wu
- The Second Clinical Medical School, Nanchang University, Nanchang, Jiangxi 330006, People's Republic of China
- These authors contributed equally to this work
| | - Zhongjie Zhang
- Xiaogan Central Hospital, Xiaogan, Hubei 432000, People's Republic of China
- These authors contributed equally to this work
| | - Kui Zhou
- School of Mechanic & Electronic Engineering, Nanchang University, Nanchang, Jiangxi 330031, People's Republic of China
| | - Weigao Chen
- Department of Orthopedic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, People's Republic of China
| | - Jun Tao
- Department of Orthopedic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, People's Republic of China
| | - Chen Li
- Department of Orthopedic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, People's Republic of China
| | - Hongbo Xin
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330031, People's Republic of China
| | - Yulin Song
- Department of Orthopedic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, People's Republic of China
| | - Fanrong Ai
- School of Mechanic & Electronic Engineering, Nanchang University, Nanchang, Jiangxi 330031, People's Republic of China
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330031, People's Republic of China
| |
Collapse
|
25
|
Li C, Xin H, Shi Y, Mu J. Knockdown of TRIM24 suppresses growth and induces apoptosis in acute myeloid leukemia through downregulation of Wnt/GSK-3β/β-catenin signaling. Hum Exp Toxicol 2020; 39:1725-1736. [PMID: 32672070 DOI: 10.1177/0960327120938845] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Tripartite motif-containing protein 24 (TRIM24) has currently emerged as a crucial cancer-related gene present in a wide range of human cancer types. However, the involvement of TRIM24 in acute myeloid leukemia (AML) has not been well investigated. The present study aims to investigate the significance, cellular function, and potential regulatory mechanism of TRIM24 in AML. We found that TRIM24 expression was significantly upregulated in AML compared with normal tissues. AML patients with low expression of TRIM24 had higher survival rates than those expressing TRIM24 at higher levels. High expression of TRIM24 was also detected in AML cells and its knockdown markedly restricted proliferation and promoted apoptosis in AML cells. Further investigation revealed that TRIM24 contributed to the regulation of Wnt/β-catenin signaling, which was associated with modulating the phosphorylation status of glycogen synthase kinase-3β (GSK-3β). Inactivation of GSK-3β partially reversed the TRIM24 knockdown-mediated antitumor effects observed in AML cells. Furthermore, knockdown of TRIM24 retarded the growth of AML-derived xenograft tumors in nude mice in vivo. Overall, these findings demonstrate that knockdown of TRIM24 impedes the AML tumor growth through the modulation of Wnt/GSK-3β/β-catenin signaling. These findings highlight the potential TRIM24 as an attractive anticancer target to treat AML.
Collapse
Affiliation(s)
- C Li
- Department of General Practice, 162798The First Affiliated Hospital of Xi'an Medical University, Xi'an, China.,Department of Cardiology, 162798The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
| | - H Xin
- Department of Cardiology, 162798The First Affiliated Hospital of Xi'an Medical University, Xi'an, China
| | - Y Shi
- Department of General Practice, 162798The First Affiliated Hospital of Xi'an Medical University, Xi'an, China
| | - J Mu
- Department of Cardiology, 162798The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
| |
Collapse
|
26
|
Li C, Hao W, Wu C, Li W, Tao J, Ai F, Xin H, Wang X. Injectable and bioactive bone cement with moderate setting time and temperature using borosilicate bio-glass-incorporated magnesium phosphate. ACTA ACUST UNITED AC 2020; 15:045015. [PMID: 31851951 DOI: 10.1088/1748-605x/ab633f] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
In this study, borosilicate bio-glass (BG) was incorporated into magnesium phosphate cement (MPC) for the purpose of developing an injectable and bioactive composite cement with suitable physicochemical and biocompatible performance. Results show that the BG-incorporated MPC possesses an excellent injectability, and can be used to fill in different 3D printed defect models using a syringe with a moderate setting time. Meanwhile, BG can retard the setting time and adjust the exothermic temperature of MPC. When the MPC/BG ratio was 3:1 (MPC3-BG), its corresponding setting time, peak temperature, anti-washout ratio and compressive strength were 9.9 ± 0.7 min, 45.8 ± 1.6 °C, 87%-90% and 13.5 MPa, respectively, which were suitable for injection and bone reparation. Characterizations of MPC3-BG showed that it had a faster degradation rate than MPC and the functional ions of boron and silicon could be released from the dissolution of the composite cement. In vitro and in vivo experiments also demonstrated that MPC3-BG had a stimulatory effect on the cell proliferation and new bone regeneration.
Collapse
Affiliation(s)
- Chen Li
- Department of Orthopedic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, People's Republic of China
| | | | | | | | | | | | | | | |
Collapse
|
27
|
Abstract
BECN1/Beclin1 is one of the key proteins in autophagy regulation. However, the biological functions of BECN1 in non-small cell lung cancer (NSCLC) were obscure. Here, we found that neither BECN1 knockdown nor overexpression affected the proliferation of NSCLC cells. Surprisingly, BECN1 overexpression increased cell migration and knocking down BECN1 significantly reduced the migratory ability of NSCLC cells. We further demonstrated that BECN1 could interact with Vimentin and affected its K48-linked ubiquitination. What’s more, BECN1 could also interact with ubiquitin-specific peptidase 14 (USP14), the key de-ubiquitinase of Vimentin, and regulated USP14 mediated de-ubiquitination of Vimentin. Thus, our studies revealed an oncosupportive role of BECN1 in the migration of NSCLC cells through regulating the ubiquitination of Vimentin.
Collapse
Affiliation(s)
- Zhujun Cheng
- a Jiangxi Institute of Respiratory Disease , The First Affiliated Hospital of Nanchang University , Nanchang , P.R. China.,b Department of Burn , The First Affiliated Hospital of Nanchang University , Nanchang , P.R. China.,c The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine , Nanchang University , Nanchang , P.R. China
| | - Hongbo Xin
- c The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine , Nanchang University , Nanchang , P.R. China
| | - Tianyu Han
- a Jiangxi Institute of Respiratory Disease , The First Affiliated Hospital of Nanchang University , Nanchang , P.R. China
| |
Collapse
|
28
|
Affiliation(s)
- H.-L. Zuo
- Department of Gynecology and Obstetrics, Second Hospital of Hebei Medical University, Shijiazhuang, China
| | - H. Xin
- Department of Gynecology and Obstetrics, Second Hospital of Hebei Medical University, Shijiazhuang, China
| | - X.-N. Yan
- Department of Ultrasonic Diagnosis and Treatment in Obstetrics and Gynecology, Second Hospital of Hebei Medical University, Shijiazhuang, China
| | - J. Huang
- Department of Gynecology and Obstetrics, Second Hospital of Hebei Medical University, Shijiazhuang, China
| | - Y.-P. Zhang
- Department of Gynecology and Obstetrics, Second Hospital of Hebei Medical University, Shijiazhuang, China
| | - H. Du
- Department of Gynecology and Obstetrics, Second Hospital of Hebei Medical University, Shijiazhuang, China
| |
Collapse
|
29
|
Liu Y, Song X, Cao F, Li F, Wang M, Yang Y, Liu M, Liu A, Xin H, Wang X. Banana Peel-Derived Dendrite-Shaped Au Nanomaterials with Dual Inhibition Toward Tumor Growth and Migration. Int J Nanomedicine 2020; 15:2315-2322. [PMID: 32308383 PMCID: PMC7132266 DOI: 10.2147/ijn.s211076] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2019] [Accepted: 02/21/2020] [Indexed: 11/23/2022] Open
Abstract
Purpose In order to prepare functional Au nanoparticles with low toxicity and high antitumor properties, we have used fruit waste (banana peel) to synthesize a new dendrite-shaped gold nanoparticle and used it for the treatment of tumors. Methods Dendrite-shaped gold nanoparticle (Au-dendrite) was synthesized through a facile hydrothermal process. The banana peel was used as both the reducing agent and the protective agent for reducing chloroauric acid to obtain Au-dendrite. The safety assessment of the Au-dendrite was conducted by H&E staining of the mouse’s eyelid skin and CCK-8 assay. The antitumor effects were evaluated through in vitro tumor cytotoxicity experiments and in vivo treatment of animal tumors. Results In this work, a new type of gold nanomaterial (Au-dendrite) was synthesized by using a common agricultural waste (banana peel) through a facile hydrothermal process without any extra chemical reducing agent or protective agent. Subsequent experiments showed that, compared with some classical Au nanomaterials, the as-synthesized gold nanocomposites have superior biocompatibility and impressive characteristics of dual inhibition toward tumor growth and migration. Conclusion We successfully synthesized a dendrite-shaped gold nanocomposite which was derived from a common agricultural waste (banana peel). A facile and environmentally friendly synthetic process was proposed accordingly without regular chemical additives. The as-prepared Au-dendrite nanocomposites not only had better biocompatibility than some classical gold nanoparticles but also exhibited unique advantages in tumor inhibition.
Collapse
Affiliation(s)
- Yu Liu
- Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China
| | - Xiangwei Song
- College of Chemistry, Nanchang University, Nanchang 330038, People's Republic of China
| | - Fei Cao
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330038, People's Republic of China
| | - Fengshun Li
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330038, People's Republic of China
| | - Manyu Wang
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330038, People's Republic of China
| | - Yalan Yang
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330038, People's Republic of China
| | - Mingzhuo Liu
- Department of Burns, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, People's Republic of China
| | - Anwen Liu
- Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China
| | - Hongbo Xin
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330038, People's Republic of China
| | - Xiaolei Wang
- College of Chemistry, Nanchang University, Nanchang 330038, People's Republic of China.,Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330038, People's Republic of China
| |
Collapse
|
30
|
Osman I, He X, Liu J, Dong K, Wen T, Zhang F, Yu L, Hu G, Xin H, Zhang W, Zhou J. TEAD1 (TEA Domain Transcription Factor 1) Promotes Smooth Muscle Cell Proliferation Through Upregulating SLC1A5 (Solute Carrier Family 1 Member 5)-Mediated Glutamine Uptake. Circ Res 2020; 124:1309-1322. [PMID: 30801233 PMCID: PMC6493685 DOI: 10.1161/circresaha.118.314187] [Citation(s) in RCA: 49] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
Supplemental Digital Content is available in the text. Rationale: TEAD (TEA domain transcription factor) 1—a major effector of the Hippo signaling pathway—acts as an oncoprotein in a variety of tumors. However, the function of TEAD1 in vascular smooth muscle cells (VSMCs) remains unclear. Objective: To assess the role of TEAD1 in vascular injury–induced smooth muscle proliferation and delineate the mechanisms underlying its action. Methods and Results: We found that TEAD1 expression is enhanced in mouse femoral artery after wire injury and correlates with the activation of mTORC1 (mechanistic target of rapamycin complex 1) signaling in vivo. Using an inducible smooth muscle–specific Tead1 KO (knockout) mouse model, we found that specific deletion of Tead1 in adult VSMCs is sufficient to attenuate arterial injury–induced neointima formation due to inhibition of mTORC1 activation and VSMC proliferation. Furthermore, we found that TEAD1 plays a unique role in VSMCs, where it not only downregulates VSMC differentiation markers but also activates mTORC1 signaling, leading to enhanced VSMC proliferation. Using whole-transcriptome sequencing analysis, we identified Slc1a5 (solute carrier family 1 member 5)—a key glutamine transporter—as a novel TEAD1 target gene. SLC1A5 overexpression mimicked TEAD1 in promoting mTORC1 activation and VSMC proliferation. Moreover, depletion of SLC1A5 by silencing RNA or blocking SLC1A5-mediated glutamine uptake attenuated TEAD1-dependent mTORC1 activation and VSMC proliferation. Conclusions: Our study unravels a novel mechanism by which TEAD1 promotes VSMC proliferation via transcriptional induction of SLC1A5, thereby activating mTORC1 signaling and promoting neointima formation.
Collapse
Affiliation(s)
- Islam Osman
- From the Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University (I.O., K.D., G.H., J.Z.)
| | - Xiangqin He
- Institute of Translational Medicine (X.H., H.X.), Nanchang University, China.,School of Life Sciences (X.H., H.X.), Nanchang University, China
| | - Jinhua Liu
- Department of Respiratory Medicine (J.L., W.Z.), The First Affiliated Hospital of Nanchang University, China
| | - Kunzhe Dong
- From the Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University (I.O., K.D., G.H., J.Z.)
| | - Tong Wen
- Department of Cardiology (T.W.), The First Affiliated Hospital of Nanchang University, China
| | - Fanzhi Zhang
- Department of Cardiology, Jiangxi Provincial People's Hospital, Nanchang, China (F.Z.)
| | - Luyi Yu
- From the Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University (I.O., K.D., G.H., J.Z.)
| | - Guoqing Hu
- From the Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University (I.O., K.D., G.H., J.Z.)
| | - Hongbo Xin
- Institute of Translational Medicine (X.H., H.X.), Nanchang University, China.,School of Life Sciences (X.H., H.X.), Nanchang University, China
| | - Wei Zhang
- Department of Respiratory Medicine (J.L., W.Z.), The First Affiliated Hospital of Nanchang University, China
| | - Jiliang Zhou
- From the Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University (I.O., K.D., G.H., J.Z.)
| |
Collapse
|
31
|
Xin H, Cao X, Zhang H, Liu J, Pan S, Li X, Guan L, Shen F, Liu Z, Wang D, Guan X, Yan J, Li H, Feng B, Zhang M, Yang Q, Jin Q, Gao L. Dynamic changes of interferon gamma release assay results with latent tuberculosis infection treatment. Clin Microbiol Infect 2020; 26:1555.e1-1555.e7. [PMID: 32062048 DOI: 10.1016/j.cmi.2020.02.009] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2019] [Revised: 02/02/2020] [Accepted: 02/08/2020] [Indexed: 11/28/2022]
Abstract
OBJECTIVES Using QuantiFERON-TB Gold In-Tube (QFT-GIT) for monitoring tuberculosis (TB) and latent TB infection treatment effect is controversial. The present study aimed to evaluate the dynamic changes of interferon gamma (IFN-γ) levels along with latent TB infection treatment via a randomized controlled study. METHODS A total of 910 participants treated with 8 weeks of once-weekly rifapentine plus isoniazid (group A), 890 treated with 6 weeks of twice-weekly rifapentine plus isoniazid (group B) and 818 untreated controls (group C) were followed for 2 years to track active TB development. QFT-GIT tests were repeated three times for all groups: before treatment (T0), at completion of treatment (T1) and 3 months after completion of treatment (T2). RESULTS Similar rates of persistent QFT-GIT reversion were observed in groups A (19.0%, 173/910), B (18.5%, 165/890) and C (20.7%, 169/818) (p 0.512). The dynamic changes of IFN-γ levels were not statistically significant among the three groups. In treated participants, individuals with higher baseline IFN-γ levels showed increased TB occurrence (1.0%, 9/896) compared to those with lower baseline levels (0.2%, 2/904) (p 0.037). A similar but statistically insignificant trend was also observed in untreated controls (1.8% (7/400) vs. 0.5% (2/418), p 0.100). When TB cases were matched with non-TB cases on baseline IFN-γ levels, no significant differences were found with respect to the dynamic changes in IFN-γ levels with time, regardless of whether they received treatment. CONCLUSIONS QFT-GIT reversion or decreased IFN-γ levels should not be used for monitoring host response to latent TB infection treatment.
Collapse
Affiliation(s)
- H Xin
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China
| | - X Cao
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China
| | - H Zhang
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China
| | - J Liu
- The Sixth People's Hospital of Zhengzhou, PR China
| | - S Pan
- The Centers for Disease Prevention and Control of Zhongmu County, Zhengzhou, PR China
| | - X Li
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China
| | - L Guan
- The Sixth People's Hospital of Zhengzhou, PR China
| | - F Shen
- The Sixth People's Hospital of Zhengzhou, PR China
| | - Z Liu
- The Centers for Disease Prevention and Control of Zhongmu County, Zhengzhou, PR China
| | - D Wang
- The Centers for Disease Prevention and Control of Zhongmu County, Zhengzhou, PR China
| | - X Guan
- The Sixth People's Hospital of Zhengzhou, PR China
| | - J Yan
- The Centers for Disease Prevention and Control of Zhongmu County, Zhengzhou, PR China
| | - H Li
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China
| | - B Feng
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China
| | - M Zhang
- Guangdong Key Laboratory for Diagnosis &Treatment of Emerging Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen University School of Medicine, Shenzhen, PR China
| | - Q Yang
- Guangdong Key Laboratory for Diagnosis &Treatment of Emerging Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen University School of Medicine, Shenzhen, PR China
| | - Q Jin
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China
| | - L Gao
- NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
| | | |
Collapse
|
32
|
Pan G, Liu Q, Xin H, Liu J. The key regulation of miR-124-3p during reprogramming of primary mouse hepatocytes into insulin-producing cells. Biochem Biophys Res Commun 2020; 522:315-321. [PMID: 31761319 DOI: 10.1016/j.bbrc.2019.11.058] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2019] [Accepted: 11/08/2019] [Indexed: 12/22/2022]
Abstract
Based on the action of small molecule compounds, the efficiency of differentiation of mouse primary hepatocytes into insulin-producing cells (IPCs) was improved by changing the expression of miR-124-2p. Hepatocytes were transfected with microRNA-124-3p (miR-124-3p) mimic or inhibitor, followed by a chemical-defined culture system for maturation of IPCs. Then, detect the expression of insulin-related genes and protein and insulin secretion of each stage during differentiation. The expression of Foxa2, PDX1, NeuroD, insulin1, and insulin2 in IPCs in the miR-124-3p inhibition expression group was significantly upregulated, while the results were opposite in the miR-124-3p overexpression group. The results of cell immunofluorescence and glucose stimulation in vitro of the miR-124-3p inhibition expression group showed that the expression of insulin, PDX1, and C-peptide was increased, and the differentiation efficiency was higher than those of the control group and overexpression group. The primary mouse hepatocytes were successfully reprogrammed into IPCs by small-molecule compounds. We found that miR-124-3p plays a negative regulatory role in the differentiation of hepatocytes into IPCs in vitro. Inhibition of miR-124-3p expression significantly increased the expression of FOXA2 and PDX1, promoted the differentiation of hepatocytes into IPCs, and increased the induction efficiency.
Collapse
Affiliation(s)
- Gui Pan
- Department of Endocrinology, The Second Affiliated Hospital of Nanchang University, Nanchang, China; Department of Respiratory, People's Hospital of Jingdezhen of Jiangxi Province, Jingdezhen, China
| | - Quanwen Liu
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China
| | - Jianping Liu
- Department of Endocrinology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
| |
Collapse
|
33
|
Jin L, Hu P, Wang Y, Wu L, Qin K, Cheng H, Wang S, Pan B, Xin H, Zhang W, Wang X. Fast-Acting Black-Phosphorus-Assisted Depression Therapy with Low Toxicity. Adv Mater 2020; 32:e1906050. [PMID: 31777995 DOI: 10.1002/adma.201906050] [Citation(s) in RCA: 60] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/15/2019] [Revised: 10/22/2019] [Indexed: 06/10/2023]
Abstract
A black phosphorus (BP)-nanosheet-based drug-delivery system containing a therapeutic drug (Fluoxetine, Flu) is synthesized. According to subsequent behavioral, biochemical, and electrophysiological analysis, BP-Flu, after irradiated with near-infrared light (808 nm), can significantly reduce the therapy time of depression. Meanwhile, the inherent biotoxicity of Flu is also alleviated.
Collapse
Affiliation(s)
- Liguo Jin
- College of Chemistry, Nanchang University, Nanchang, Jiangxi, 330088, China
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330088, China
| | - Ping Hu
- The Center for Biotechnology and Biopharmaceutics, Institute of Translational Medicine, Nanchang University, Nanchang, 330031, China
| | - Yinyin Wang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330088, China
| | - Luojia Wu
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330088, China
| | - Kang Qin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330088, China
| | - Haoxin Cheng
- College of Chemistry, Nanchang University, Nanchang, Jiangxi, 330088, China
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330088, China
| | - Shuhua Wang
- College of Chemistry, Nanchang University, Nanchang, Jiangxi, 330088, China
| | - Bingxing Pan
- Laboratory of Fear and Anxiety Disorders, Institute of Life Science, Nanchang University, Nanchang, Nanchang, 330031, China
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330088, China
| | - Wenhua Zhang
- Laboratory of Fear and Anxiety Disorders, Institute of Life Science, Nanchang University, Nanchang, Nanchang, 330031, China
| | - Xiaolei Wang
- College of Chemistry, Nanchang University, Nanchang, Jiangxi, 330088, China
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330088, China
| |
Collapse
|
34
|
Wang H, Chen T, Chen Y, Luo T, Tan B, Chen H, Xin H. Evaluation of the inhibitory effects of vaginal microorganisms on sperm motility in vitro. Exp Ther Med 2019; 19:535-544. [PMID: 31853321 PMCID: PMC6909777 DOI: 10.3892/etm.2019.8237] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2019] [Accepted: 10/31/2019] [Indexed: 12/16/2022] Open
Abstract
Female infertility usually occurs as a result of ageing, physical impairment, hormone disturbances and lifestyle or environmental factors. However, the potential role of Lactobacillus in female infertility has remained largely unexplored. In the present study, high-throughput sequencing, real-time PCR, bacterial adherence assays and sperm motility assays were used to evaluate the microbial diversity, adherence properties and effect on sperm motility of sperm bacteria, vaginal bacteria and vaginal bacteria that had been co-cultured with sperm. The results indicated that in the co-culture group, Lactobacillus adhered to sperm cells in numbers that were 332-fold higher than those of control species Enterococcus and analysis of sequencing data using the Kyoto Encyclopedia of Genes and Genomes indicated that adhered microbes reduced sperm cell motility. Vaginal isolates, as well as bacterial strains used as controls, were co-cultured with sperm and it was indicated that all strains were able to adhere to sperm cells in large numbers. The probiotic Lactobacillus (L.) strains L. crispatus, L. acidophilus, L. helveticus and L. gasseri significantly reduced sperm motility (based on measurements of general, straightforward and non-straightforward progressive motility, total motility and average path velocity; P<0.05). Furthermore, L. crispatus, L. acidophilus, L. salivarius, L. helveticus and L. gasseri markedly reduced sperm penetration in a viscous medium. Based on these results, it may be hypothesized that the weakening effect of Lactobacillus on sperm motility may be beneficial for healthy couples to prevent the combination of abnormal sperms and eggs, but may be detrimental for males with severe asthenospermia, oligospermia or aspermia.
Collapse
Affiliation(s)
- Huan Wang
- School of Life Sciences, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330031, P.R. China
| | - Tingtao Chen
- School of Life Sciences, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330031, P.R. China
| | - Yidan Chen
- School of Life Sciences, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330031, P.R. China
| | - Tao Luo
- National Engineering Research Center for Bioengineering Drugs and Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330031, P.R. China
| | - Buzhen Tan
- Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
| | - Houyang Chen
- Reproductive Medical Centre, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi 330031, P.R. China
| | - Hongbo Xin
- School of Life Sciences, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330031, P.R. China
| |
Collapse
|
35
|
Zhao ZG, Wang HF, Wang YW, Li J, Li YX, Xin H, Liu JJ, Guan XM. The mechanisms of Ang II-induced hypertensive vascular remodeling under suppression of CD68 in macrophages. Eur Rev Med Pharmacol Sci 2019; 22:6093-6099. [PMID: 30280796 DOI: 10.26355/eurrev_201809_15948] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE High blood pressure (hypertension) is one of the most common cardiovascular diseases. In recent years, there were more and more studies on the function of inflammation in hypertension. CD68 mainly mediates the activation of cytokine interleukin-17 (IL-17) signaling pathway and participates in inflammatory responses. It has been studied the function of CD68 and IL-17 in hypertension, but it has not been reported whether it affected hypertension and vascular remodeling when macrophage CD68 expression inhibited. In this study, antisense-CD68 mice were used to study the effect and mechanism of angiotensin II-induced hypertensive vascular remodeling under specific suppression of macrophage CD68. MATERIALS AND METHODS Fifty 8-week-old male antisense-CD681 and C57 mice were divided into control and experimental group (angiotensin II group, 1000 ng•kg-1•min-1). After infusion of angiotensin II for 28 days, hematoxylin-eosin (HE) staining and immunohistochemical staining were used to observe the remodel of vascular. The changes of aortic inflammatory factors were detected by Real-time PCR (RT-PCR) and Western blotting. RESULTS By specifically inhibiting the expression of macrophage CD68, macrophage infiltration was mitigated in Ang II-induced hypertensive vascular remodeling model mouse, which also down-regulated the expression of vascular tissue inflammatory factor and activation of vascular smooth muscle cell p65. CONCLUSIONS CD68 regulates the Ang II-induced hypertensive vascular remodeling through mediating macrophage inflammatory factor release.
Collapse
Affiliation(s)
- Z-G Zhao
- Department of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
| | | | | | | | | | | | | | | |
Collapse
|
36
|
Li R, Cao F, Chen Y, Zhang P, Huang C, Xin H, Wang J, Wang X. Metal–Organic Framework and Hydrogel Based Strategy as a Universal First-Aid Treatment of Three Different Typical Snake Bites. ACS Biomater Sci Eng 2019; 5:6265-6273. [DOI: 10.1021/acsbiomaterials.9b01388] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Ruolei Li
- The National Engineering Research Center for Bioengineering Drugs and the Technologies: Institition of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
- College of Queen Mary, Nanchang University, Nanchang, Jiangxi 330031, China
| | - Fei Cao
- The National Engineering Research Center for Bioengineering Drugs and the Technologies: Institition of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Yutong Chen
- The National Engineering Research Center for Bioengineering Drugs and the Technologies: Institition of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Peixin Zhang
- College of Resource, Environmental and Chemical Engineering, Nanchang University, Nanchang, Jiangxi 330031, China
| | - Chunhong Huang
- College of Basic Medicine, Nanchang University, Nanchang, Jiangxi 330031, China
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies: Institition of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Jun Wang
- College of Resource, Environmental and Chemical Engineering, Nanchang University, Nanchang, Jiangxi 330031, China
| | - Xiaolei Wang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies: Institition of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
- College of Chemistry, Nanchang University, Nanchang, Jiangxi 330031, China
| |
Collapse
|
37
|
Dong K, He X, Su H, Xin H, Zhou J. Abstract P2013: Genomic Identification Of Key CircRNAs In Healthy And Dilated Cardiomyopathy Human Heart. Hypertension 2019. [DOI: 10.1161/hyp.74.suppl_1.p2013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Heart failure is a leading cause of morbidity and mortality. Dilated cardiomyopathy (DCM) is a primary cause of heart failure and sudden cardiac death worldwide. Therefore, it is important to identify factors that function in both normal and diseased hearts for a better understanding of etiology of DCM. CircRNA is a newly discovered class of RNA molecule and has been found to play a critical role in both physiological and pathological conditions. In this study, we systematically analyzed whole transcriptome data of five normal and five DCM human heart samples to identify putative key circRNAs and predict their potential underlying mechanisms. Our results revealed that many circRNAs produced from known cardiac diseases-related gene loci are dysregulated in DCM, such as circRNAs originated from
TTN
and
RYR2
. Furthermore, our analysis revealed 40 conserved circRNAs that are putatively important in normal or DCM human heart, including 14 circRNAs with potential to act as sponges for DCM-related miRNAs and 4 circRNAs with potential coding ability. Importantly, our results identified that a novel class of circRNA, fusion-circRNAs are originated from
MYH6
and
MYH7
genes and exhibit most abundant expression in human heart with high conservation between different species. Furthermore, these fusion-circRNAs were dysregulated in DCM and have strong potential to sponge DCM-related miRNAs. In summary, our findings serve as a valuable resource for exploration of the function of circRNAs in human heart diseases.
Collapse
|
38
|
Fang B, Dong L, Ding X, Ren Y, Lv Z, Liu K, Zhang F, Zhang W, Deng J, Xin H, Wang X. Black fungus derived aerogel with double faced properties. CHINESE CHEM LETT 2019. [DOI: 10.1016/j.cclet.2019.04.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/09/2022]
|
39
|
Lin J, Ding X, Hong C, Pang Y, Chen L, Liu Q, Zhang X, Xin H, Wang X. Several biological benefits of the low color temperature light-emitting diodes based normal indoor lighting source. Sci Rep 2019; 9:7560. [PMID: 31101840 PMCID: PMC6525242 DOI: 10.1038/s41598-019-43864-6] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2019] [Accepted: 03/04/2019] [Indexed: 12/01/2022] Open
Abstract
Currently, light pollution has become a nonnegligible issue in our daily life. Artificial light sources with high color temperature were deem to be the major pollution source, which could induce several adverse effects on human’s health. In our previous research, we have firstly developed an artificial indoor light with low color temperature (1900 K). However, the biological effects of this artificial light on human’s health are unclear. Here, four artificial lights (1900 K, 3000 K, 4000 K and 6600 K) were used to evaluate some biological changes in both human (in total 152 person-times) and murine models. Compared with other three high color temperature artificial lights, our lights (1900 K) presented a positive effect on promoting the secreting of melatonin and glutamate, protecting human’s eyes, accelerating would healing and hair regeneration. These systematical studies indicated that the proposed low color temperature (1900 K) light could provide several significant benefits in human’s daily life.
Collapse
Affiliation(s)
- Jiaqi Lin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330031, China
| | - Xingwei Ding
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330031, China
| | - Can Hong
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330031, China
| | - Yulian Pang
- Affiliated Eye Hospital of Nanchang University, Jiangxi Research Institute of Ophthalmology & Visual Science, Nanchang, Jiangxi, 330088, China
| | - Liming Chen
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330031, China
| | - Quanwen Liu
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330031, China
| | - Xu Zhang
- Affiliated Eye Hospital of Nanchang University, Jiangxi Research Institute of Ophthalmology & Visual Science, Nanchang, Jiangxi, 330088, China
| | - Hongbo Xin
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330031, China
| | - Xiaolei Wang
- The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330031, China.
| |
Collapse
|
40
|
Li T, Fang F, Yang Y, Shen W, Bao W, Zhang T, Ai F, Ding X, Xin H, Wang X. Surface nano-engineered wheat straw for portable and adjustable water purification. Sci Total Environ 2019; 655:1028-1036. [PMID: 30577097 DOI: 10.1016/j.scitotenv.2018.11.206] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/14/2018] [Revised: 10/25/2018] [Accepted: 11/14/2018] [Indexed: 06/09/2023]
Abstract
Wheat straw (WS), as a cheap and abundant agricultural waste, is usually burned directly in farmland and causes severe air pollution. Therefore, biochar derived from waste WS is prepared and modified by nanoscaled zinc oxide through a facile in-situ surface-modification process. For ease of use, a 3D printed finger-sized unit (FSU) loaded with the above as-prepared WS is designed and implemented. Each unit weighs only 4 g, and could simultaneously reduce three major water contaminants: bacteria, organic dyes, and heavy metal ions. Moreover, it is interesting to note that fresh wheat straw is a flexible material and has excellent electrical conductivity after carbonization. These two properties (flexibility and conductivity) could further adjust water purification performance. The subsequent cellular and animal tests confirmed the biosafety of the water purified with FSU alone.
Collapse
Affiliation(s)
- Ting Li
- College of Chemistry, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Fang Fang
- Institute of Material, Nanchang University, Nanchang, Jiangxi 330096, China
| | - Yu Yang
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Wanji Shen
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Weiwei Bao
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Tianran Zhang
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Fanrong Ai
- School of Mechanical & Electrical Engineering, Nanchang University, Nanchang, Jiangxi 330031, China
| | - Xingwei Ding
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Hongbo Xin
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Xiaolei Wang
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China.
| |
Collapse
|
41
|
Zhang HJ, Dou RC, Lin L, Wang QY, Huang BE, Zhao XL, Chen DJ, Ding YL, Ding HJ, Cui SH, Zhang WS, Xin H, Gu WR, Hu YL, Ding GF, Qi HB, Fan L, Ma YY, Lu JL, Yang Y, Lin L, Luo XC, Zhang XH, Fan SR, Yang HX. [Risk factors and sonographic findings associated with the type of placenta accreta spectrum disorders]. Zhonghua Fu Chan Ke Za Zhi 2019; 54:27-32. [PMID: 30695903 DOI: 10.3760/cma.j.issn.0529-5675.2019.01.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the risk factors and sonographic findings of pregnancies complicated by placenta increta or placenta percreta. Methods: Totally, 2 219 cases were retrospectively analyzed from 20 tertiary hospitals in China from January 2011 to December 2015. The data were collected based on the original case records. All cases were divided into two groups, the placenta increta (PI) group (79.1%, 1 755/2 219) and the placenta percreta (PP) group (20.9%, 464/2 219) , according to the degree of placental implantation. The risk factors and sonographic findings of placenta increta or percreta were analyzed by uni-factor and logistic regression statistic methods. Results: The risk factors associated with the degree of placental implantation were age, gravida, previous abortion or miscarriage, previous cesarean sections, and placenta previa (all P<0.05), especially, previous cesarean sections (χ(2)=157.961) and placenta previa (χ(2)=91.759). Sonographic findings could be used to predict the degree of placental invasion especially the boundaries between placenta and uterine serosa, the boundary between placenta and myometrium, the disruption of the placental-uterine wall interface and loss of the normal retroplacental hypoechoic zone(all P<0.01). Conclusions: Previous cesarean sections and placenta previa are the main independent risk factors associated with the degree of placenta implantation. Ultrasound could be used to make a prenatal suggestive diagnosis of placenta accreta spectrum disorders.
Collapse
Affiliation(s)
- H J Zhang
- Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China
| | - R C Dou
- Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China
| | - L Lin
- Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China
| | - Q Y Wang
- Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China
| | - B E Huang
- Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China
| | - X L Zhao
- Department of Obstetrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - D J Chen
- Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China
| | - Y L Ding
- Department of Obstetrics and Gynecology, The Second Xiangya Hospital of Central South University, Changsha 410008, China
| | - H J Ding
- Department of Obstetrics and Gynecology, Nanjing Maternity and Child Health Hospital, the Affiliated Obstetrics and Gynecology Hospital of Nanjing Medical University, Nanjing 210004, China
| | - S H Cui
- Department of Obstetrics, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - W S Zhang
- Department of Obstetrics and Gynecology, Xiangya Hospital of Central South University, Changsha 410008, China
| | - H Xin
- Department of Obstetrics, The Second Affiliated Hospital of Hebei Medical University, Shijiazhuang 050000, China
| | - W R Gu
- Department of Obstetrics, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, China
| | - Y L Hu
- Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210093, China
| | - G F Ding
- Department of Obstetrics, Urumqi Maternity and Child Health Hospital, Urumqi 830001, China
| | - H B Qi
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China
| | - L Fan
- Department of Obstetrics, Beijing Obstetrics and Gynecology Hospital of Capital Medical University, Beijing 100026, China
| | - Y Y Ma
- Department of Obstetrics and Gynecology, Qilu Hospital of Shangdong University, Ji'nan 266035, China
| | - J L Lu
- Department of Obstetrics and Gynecology, Beijing Chaoyang Hospital of Capital Medical University, Beijing 100043, China
| | - Y Yang
- Department of Obstetrics and Gynecology, Civil Aviation General Hospital of Peking University, Beijing 100025, China
| | - L Lin
- Department of Obstetrics and Gynecology, Beijing Friendship Hospital of Capital Medical University, Beijing 100050, China
| | - X C Luo
- Department of Obstetrics, Lianyungang Maternity and Child Health Hospital, Lianyungang 100142, China
| | - X H Zhang
- Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China
| | - S R Fan
- Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen 518035, China
| | - H X Yang
- Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China
| |
Collapse
|
42
|
Dong L, Liu X, Wang T, Fang B, Chen J, Li C, Miao X, Wei C, Yu F, Xin H, Hong K, Ding X, Wang X. Localized Light-Au-Hyperthermia Treatment for Precise, Rapid, and Drug-Free Blood Clot Lysis. ACS Appl Mater Interfaces 2019; 11:1951-1956. [PMID: 30571091 DOI: 10.1021/acsami.8b20616] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Thrombus diseases, induced by blood stasis or vascular embolization normally, frequently occur with high disability and mortalities worldwide. At present, drug thrombolysis, a primary clinical therapy for blood clot lysis, could increase the lethal risk for hemorrhage when thrombolysis agents are overused in the whole body. Therefore, a novel and advanced therapy for blood clot lysis, based on remote physical signals, is helpful for assisting clinical therapy. Here, we used the localized light-Au-hyperthermia (LAH) treatment, induced by gold nanorods (Au NRs) irradiated with near-infrared light (808 nm), for precise, rapid, and drug-free blood clot lysis. The LAH technology was first introduced in the murine hematoma model and the murine myocardial infarction model for blood clot lysis. Compared with traditional therapy, LAH was assured to shorten the time of detumescence in the murine hematoma model owing to their precise and localized hyperthermia. Meanwhile, we also discovered that LAH was a benefit to vascular recanalization in the murine myocardial infarction model. In addition, the Au NRs used in LAH present ideal biocompatibility in the murine model, which endows it to be suitable for blood clot lysis in vivo.
Collapse
Affiliation(s)
- Lina Dong
- Institute of Translational Medicine , Nanchang University , Nanchang , Jiangxi 330088 , China
| | - Xiao Liu
- Jiangxi Key Laboratory of Molecular Medicine , Nanchang , Jiangxi 330006 , China
| | - Tian Wang
- Institute of Translational Medicine , Nanchang University , Nanchang , Jiangxi 330088 , China
| | - Bixing Fang
- Department of Otolaryngology Head & Neck Surgery , The Third Affiliated Hospital of Sun Yat-sen University , Guangzhou , Guangdong 510630 , China
| | - Jinghuang Chen
- Institute of Translational Medicine , Nanchang University , Nanchang , Jiangxi 330088 , China
| | | | | | - Chaochao Wei
- Institute of Translational Medicine , Nanchang University , Nanchang , Jiangxi 330088 , China
| | - Fen Yu
- Institute of Translational Medicine , Nanchang University , Nanchang , Jiangxi 330088 , China
| | - Hongbo Xin
- Institute of Translational Medicine , Nanchang University , Nanchang , Jiangxi 330088 , China
| | - Kui Hong
- Jiangxi Key Laboratory of Molecular Medicine , Nanchang , Jiangxi 330006 , China
| | - Xingwei Ding
- Institute of Translational Medicine , Nanchang University , Nanchang , Jiangxi 330088 , China
| | - Xiaolei Wang
- Institute of Translational Medicine , Nanchang University , Nanchang , Jiangxi 330088 , China
| |
Collapse
|
43
|
Zhang W, Hu J, Zhou Y, Chen Y, Yu F, Hong C, Chen L, Xin H, Hong K, Wang X. Latex and a ZnO-based multi-functional material for cardiac implant-related inflammation. Biomater Sci 2019; 7:4186-4194. [DOI: 10.1039/c9bm00952c] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
A new memory latex foam with ZnO modification was developed to reduce the incidence of both bacteria- and shaking-induced pocket inflammation.
Collapse
Affiliation(s)
- Wei Zhang
- College of Chemistry
- Nanchang University
- Nanchang
- P.R. China
| | - Jinzhu Hu
- Department of Cardiovascular Medicine
- The Second Affiliated Hospital of Nanchang University
- Nanchang
- P.R. China
| | - Yan Zhou
- The National Engineering Research center for Bioengineering Drugs and the Technologies
- Institute of Translational Medicine
- Nanchang University
- Nanchang
- P.R. China
| | - Yutong Chen
- The National Engineering Research center for Bioengineering Drugs and the Technologies
- Institute of Translational Medicine
- Nanchang University
- Nanchang
- P.R. China
| | - Fen Yu
- College of Chemistry
- Nanchang University
- Nanchang
- P.R. China
| | - Can Hong
- The National Engineering Research center for Bioengineering Drugs and the Technologies
- Institute of Translational Medicine
- Nanchang University
- Nanchang
- P.R. China
| | - Liming Chen
- College of Chemistry
- Nanchang University
- Nanchang
- P.R. China
| | - Hongbo Xin
- The National Engineering Research center for Bioengineering Drugs and the Technologies
- Institute of Translational Medicine
- Nanchang University
- Nanchang
- P.R. China
| | - Kui Hong
- Department of Cardiovascular Medicine
- The Second Affiliated Hospital of Nanchang University
- Nanchang
- P.R. China
| | - Xiaolei Wang
- College of Chemistry
- Nanchang University
- Nanchang
- P.R. China
- The National Engineering Research center for Bioengineering Drugs and the Technologies
| |
Collapse
|
44
|
Cheng Z, Wen Y, Liang B, Chen S, Liu Y, Wang Z, Cheng J, Tang X, Xin H, Deng L. Gene expression profile-based drug screen identifies SAHA as a novel treatment for NAFLD. Mol Omics 2019; 15:50-58. [DOI: 10.1039/c8mo00214b] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide.
Collapse
Affiliation(s)
- Zhujun Cheng
- Institute of Translational Medicine, Nanchang University
- Nanchang
- P. R. China
| | - Yusong Wen
- Institute of Translational Medicine, Nanchang University
- Nanchang
- P. R. China
| | - Bowen Liang
- School of Public Health, Nanchang University
- Nanchang
- P. R. China
| | - Siyang Chen
- School of Public Health, Nanchang University
- Nanchang
- P. R. China
| | - Yujun Liu
- Queen Mary School, Medical College, Nanchang University
- Nanchang
- P. R. China
| | - Zang Wang
- School of Public Health, Nanchang University
- Nanchang
- P. R. China
| | - Jiayu Cheng
- The Fourth Clinical Medical College, Nanchang University
- Nanchang
- P. R. China
| | - Xiaoli Tang
- College of Basic Medical Science, Nanchang University
- Nanchang
- P. R. China
| | - Hongbo Xin
- Institute of Translational Medicine, Nanchang University
- Nanchang
- P. R. China
| | - Libin Deng
- Institute of Translational Medicine, Nanchang University
- Nanchang
- P. R. China
- College of Basic Medical Science, Nanchang University
- Nanchang
| |
Collapse
|
45
|
Yang T, Ding X, Dong L, Hong C, Ye J, Xiao Y, Wang X, Xin H. Platelet-Mimic uPA Delivery Nanovectors Based on Au Rods for Thrombus Targeting and Treatment. ACS Biomater Sci Eng 2018; 4:4219-4224. [PMID: 33418820 DOI: 10.1021/acsbiomaterials.8b00979] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Systemic thrombolytic drug administration has always gained an unideal therapeutic effect due to the rapid neutralization by its antidotes. It is significant to seek an approach for targeted thrombolytic drug delivery to the thrombus. Here a biocompatible, thrombus-targeted, and low-cost platelet-mimic nanovector was fabricated to accomplish a sustained urokinase plasminogen activator (uPA) release at the thrombus site. The prepared system presented a sustained model drug release behavior for 30 h and burst release behavior under near-infrared laser irradiation with hyperthermia in vitro. We demonstrate that the fabricated nanovectors can arrive and aggregate at the pulmonary thrombus, followed by a sustained uPA release in the murine pulmonary embolism model. Therefore, according to the results, the formulated nanovector presented a hopeful application for targeted thrombolytic therapy clinically.
Collapse
Affiliation(s)
- Ting Yang
- Institute of Translational Medicine, Nanchang University, Xuefu Road 1299, Honggutan District, Nanchang, Jiangxi 330088, China
| | - Xingwei Ding
- Institute of Translational Medicine, Nanchang University, Xuefu Road 1299, Honggutan District, Nanchang, Jiangxi 330088, China
| | - Lina Dong
- Institute of Translational Medicine, Nanchang University, Xuefu Road 1299, Honggutan District, Nanchang, Jiangxi 330088, China
| | - Can Hong
- Institute of Translational Medicine, Nanchang University, Xuefu Road 1299, Honggutan District, Nanchang, Jiangxi 330088, China
| | - Jing Ye
- Department of Orthopedic Surgery, The Second Affiliated Hospital of Nanchang University, Minde Road 1, Donghu District, Nanchang, Jiangxi 330006, China
| | - Yunfei Xiao
- Institute of Translational Medicine, Nanchang University, Xuefu Road 1299, Honggutan District, Nanchang, Jiangxi 330088, China
| | - Xiaolei Wang
- Institute of Translational Medicine, Nanchang University, Xuefu Road 1299, Honggutan District, Nanchang, Jiangxi 330088, China
| | - Hongbo Xin
- Institute of Translational Medicine, Nanchang University, Xuefu Road 1299, Honggutan District, Nanchang, Jiangxi 330088, China
| |
Collapse
|
46
|
Chen T, Zhao X, Ren Y, Wang Y, Tang X, Tian P, Wang H, Xin H. Triptolide modulates tumour-colonisation and anti-tumour effect of attenuated Salmonella encoding DNase I. Appl Microbiol Biotechnol 2018; 103:929-939. [DOI: 10.1007/s00253-018-9481-8] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2018] [Revised: 10/04/2018] [Accepted: 10/23/2018] [Indexed: 10/27/2022]
|
47
|
Li T, Ai F, Shen W, Yang Y, Zhou Y, Deng J, Li C, Ding X, Xin H, Wang X. Microstructural Orientation and Precise Regeneration: A Proof-of-Concept Study on the Sugar-Cane-Derived Implants with Bone-Mimetic Hierarchical Structure. ACS Biomater Sci Eng 2018; 4:4331-4337. [PMID: 33418828 DOI: 10.1021/acsbiomaterials.8b01052] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- Ting Li
- College of Chemistry, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Fanrong Ai
- School of Mechanical and Electrical Engineering, Nanchang University, Nanchang, Jiangxi 330031, China
| | - Wanji Shen
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Yu Yang
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Yan Zhou
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Jianjian Deng
- Department of Orthopedics Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China
| | - Chen Li
- Department of Orthopedics Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China
| | - Xinwei Ding
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Hongbo Xin
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| | - Xiaolei Wang
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330088, China
| |
Collapse
|
48
|
Lian B, Xin H, Zhimin S. Abstract P4-03-07: Combined genome-scale CRISPR-Cas9 knockout screening with transcriptome sequencing to identify paclitaxel related drivers in triple negative breast cancer. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p4-03-07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background. Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancers, for which the only standard therapeutics is chemotherapy containing Taxol. However, quite a number of TNBC patients cannot get the expected drug response after paclitaxel treatment and the resistant mechanism has not been clear yet. Other than the traditional “genotype-to-phenotype” means, the high-throughput functional screening, such as CRISPR-CAS9 library, selects genes with the phenotype of interest. Here, we combine the novel screening model with the drug-resistant genotype to explore the decisive role in paclitaxel effect.
Methods. Breast cancer cell line MDA-MB-231(231WT) was treated by paclitaxel from 1ug/ml to 5ug/ml to establish a paclitaxel-resistant cell type (231PTX) for transcriptome sequencing. Genome-scale CRISPR-Cas9 sgRNA library was made into lentivirus to affect MDA-MB-231 cells expressed Cas9 protein (231cas9). Then 231cas9-sgRNA was treated by low dose of paclitaxel for 14 days and was read by next generation sequencing. RNA sequencing data was processed to TPM values and sgRNA data to gene ranking and p value. The threshold of “231PTX TPM/231WT TPM” was above 2 or below 1/2 and the gene p value was smaller than 0.05. Biological technology applied in this study includes western blot (WB), immunofluorescence (IF), real time PCR and cell proliferation assay. In vivo, 20 balb/c mouse were injected MDA-MB-231 in situ for tumor formation and were treated with paclitaxel/normal saline for six times.
Results. Crosstalk between these two sequencing data had result of 124 genes related to paclitaxel resistance (fold change> 2 and p value<0.05 compared Day 14 treated group to Day 14 untreated group) and 18 genes related to paclitaxel sensitivity (fold change< 1/2 and p value<0.05 compared Day 14 untreated group to Day 14 treated group). Considering clinical prognosis and gene information, six paclitaxel resistant candidates and four paclitaxel sensitive candidates were chosen for further research. Eight (STRA6, BIRC3, MTUS1, HDAC9, ADAM28, S1PR5, TNNC1, ZKSCAN7) of ten candidates displayed consistent phenotypes with sequencing results including mRNA expression and the cellular proliferation in paclitaxel treatment. HDAC9 is a histone deacetylation gene that is likely to be a paclitaxel resistant gene. Knockout HDAC9 (231H9 KO) contributed to nearly 2-fold decrease IC50 value (1.7nM versus 3.7nM, p value<0.01). Confocal microscopy observed the formation of multiple spindle foci in the paclitaxel treated 231H9 KO cells. After treatment with paclitaxel, the mark of polymerized tubulin, acetylation tubulin and the mark of cell cycle G2/M, cyclin B1 were notably increased when HDAC9 knockout in both MD-MB1-231 and BT-100 cell lines. In vivo assays found that HDAC9 knockout induced the declined tumorigenesis and more sensitive breast tumors to paclitaxel.
Conclusions.Combined Genome-scale CRISPR-Cas9 knockout screening with transcriptome sequencing is efficient to investigate potent drug targets. In vitro assays suggest that HDAC9 is conductive to paclitaxel resistance in TNBC cells. In vivo results imply inhibition HDAC9 may beneficial to paclitaxel therapeutic response.
Citation Format: Lian B, Xin H, Zhimin S. Combined genome-scale CRISPR-Cas9 knockout screening with transcriptome sequencing to identify paclitaxel related drivers in triple negative breast cancer [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P4-03-07.
Collapse
Affiliation(s)
- B Lian
- Fudan University Shanghai Cancer Center, China; Shanghai Medical College, Fudan University, China
| | - H Xin
- Fudan University Shanghai Cancer Center, China; Shanghai Medical College, Fudan University, China
| | - S Zhimin
- Fudan University Shanghai Cancer Center, China; Shanghai Medical College, Fudan University, China
| |
Collapse
|
49
|
Song C, Yan H, Wang H, Zhang Y, Cao H, Wan Y, Kong L, Chen S, Xu H, Pan B, Zhang J, Fan G, Xin H, Liang Z, Jia W, Tian XL. AQR is a novel type 2 diabetes-associated gene that regulates signaling pathways critical for glucose metabolism. J Genet Genomics 2018; 45:111-120. [PMID: 29502958 DOI: 10.1016/j.jgg.2017.11.007] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2017] [Revised: 11/23/2017] [Accepted: 11/25/2017] [Indexed: 12/19/2022]
Abstract
Type 2 diabetes mellitus (T2DM) is a common metabolic disease influenced by both genetic and environmental factors. In this study, we performed an in-house genotyping and meta-analysis study using three independent GWAS datasets of T2DM and found that rs3743121, located 1 kb downstream of AQR, was a novel susceptibility SNP associated with T2DM. The risk allele C of rs3743121 was correlated with the increased expression of AQR in white blood cells, similar to that observed in T2DM models. The knockdown of AQR in HepG2 facilitated the glucose uptake, decreased the expression level of PCK2, increased the phosphorylation of GSK-3β, and restored the insulin sensitivity. Furthermore, the suppression of AQR inhibited the mTOR pathway and the protein ubiquitination process. Our study suggests that AQR is a novel type 2 diabetes-associated gene that regulates signaling pathways critical for glucose metabolism.
Collapse
Affiliation(s)
- Chun Song
- Laboratory of Human Population Genetics, Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - Han Yan
- Laboratory of Human Population Genetics, Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - Hanming Wang
- Laboratory of Human Population Genetics, Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - Yan Zhang
- State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, Peking University, Beijing 100871, China; Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, Beijing 100871, China
| | - Huiqing Cao
- Laboratory of Nucleic Acid Technology, Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - Yiqi Wan
- Human Population Genetics, Human Aging Research Institute and School of Life Sciences, Nanchang University, Nanchang 330006, China
| | - Lingbao Kong
- Human Population Genetics, Human Aging Research Institute and School of Life Sciences, Nanchang University, Nanchang 330006, China
| | - Shenghan Chen
- Human Population Genetics, Human Aging Research Institute and School of Life Sciences, Nanchang University, Nanchang 330006, China
| | - Hong Xu
- Institute of Life Science and School of Life Science, Nanchang University, Nanchang 330031, China
| | - Bingxing Pan
- Institute of Life Science and School of Life Science, Nanchang University, Nanchang 330031, China
| | - Jin Zhang
- School of Basic Medical Sciences, Nanchang University, Nanchang 330006, China
| | - Guohuang Fan
- Institute of Translational Medicine, Nanchang University, Nanchang 330031, China
| | - Hongbo Xin
- Institute of Translational Medicine, Nanchang University, Nanchang 330031, China
| | - Zicai Liang
- Laboratory of Nucleic Acid Technology, Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - Weiping Jia
- Shanghai Key Laboratory of Diabetes Mellitus and Center for Translational Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China
| | - Xiao-Li Tian
- Laboratory of Human Population Genetics, Institute of Molecular Medicine, Peking University, Beijing 100871, China; Human Population Genetics, Human Aging Research Institute and School of Life Sciences, Nanchang University, Nanchang 330006, China.
| |
Collapse
|
50
|
Dong L, Wang W, Chen J, Ding X, Fang B, Miao X, Liu Y, Yu F, Xin H, Wang X. Silver nanowire net knitted anisotropic aerogel as an ultralight and sensitive physiological activity monitor. Biomater Sci 2018; 6:2312-2315. [PMID: 30019050 DOI: 10.1039/c8bm00651b] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A versatile and ultralight physiological activity monitor using celery derived inherent anisotropic aerogels with silver nanowire knitted net decoration.
Collapse
Affiliation(s)
- Lina Dong
- Institute of Translational Medicine
- Nanchang University
- Nanchang
- China
| | - Wenyan Wang
- Institute of Translational Medicine
- Nanchang University
- Nanchang
- China
| | - Jinghuang Chen
- Institute of Translational Medicine
- Nanchang University
- Nanchang
- China
| | - Xingwei Ding
- Institute of Translational Medicine
- Nanchang University
- Nanchang
- China
| | - Bixing Fang
- Department of Otolaryngology Head & Neck Surgery
- The Third Affiliated Hospital of Sun Yat-sen University
- Guangzhou
- China
| | - Xinxin Miao
- Department of Orthopedic Surgery
- The Second Affiliated Hospital of Nanchang University
- Nanchang
- China
| | - Yu Liu
- Department of Oncology
- The Second Affiliated Hospital of Nanchang University Nanchang
- China
| | - Fen Yu
- College of Chemistry
- Nanchang University
- Nanchang
- P.R. China
| | - Hongbo Xin
- Institute of Translational Medicine
- Nanchang University
- Nanchang
- China
| | - Xiaolei Wang
- Institute of Translational Medicine
- Nanchang University
- Nanchang
- China
| |
Collapse
|